<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Med</journal-id><journal-id journal-id-type="hwp">jem</journal-id><journal-title-group><journal-title>The Journal of Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">0022-1007</issn><issn pub-type="epub">1540-9538</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">20090756</article-id><article-id pub-id-type="doi">10.1084/jem.20090756</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Beck</surname><given-names>Kristina</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Peak</surname><given-names>Mandy M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ota</surname><given-names>Takayuki</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Nemazee</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Murre</surname><given-names>Cornelis</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label><institution>Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093</institution></aff><aff id="aff2"><label>2</label><institution>Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037</institution></aff><author-notes><corresp>CORRESPONDENCE Cornelis Murre: <email>murre@biomail.ucsd.edu</email></corresp></author-notes><pub-date pub-type="ppub"><day>28</day><month>9</month><year>2009</year></pub-date><volume>206</volume><issue>10</issue><fpage>2271</fpage><lpage>2284</lpage><history><date date-type="received"><day>6</day><month>4</month><year>2009</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 Beck et al.</copyright-statement><copyright-year>2009</copyright-year><license license-type="openaccess" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p>This article is distributed under the terms of an Attribution&#x02013;Noncommercial&#x02013;Share Alike&#x02013;No Mirror Sites license for the first six months after the publication date (see <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/misc/terms.shtml">http://www.jem.org/misc/terms.shtml</ext-link>). After six months it is available under a Creative Commons License (Attribution&#x02013;Noncommercial&#x02013;Share Alike 3.0 Unported license, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0/">http://creativecommons.org/licenses/by-nc-sa/3.0/</ext-link>).</license-p></license></permissions><abstract><p>The <italic>E2A</italic> gene products, E12 and E47, are critical regulators of B cell development. However, it remains elusive whether E12 and E47 have overlapping and/or distinct functions during B lymphopoiesis. We have generated mice deficient for either E12 or E47 and examined their roles in B cell maturation. We show that E47 is essential for developmental progression at the prepro&#x02013;B cell stage, whereas E12 is dispensable for early B cell development, commitment, and maintenance. In contrast, both E12 and E47 play critical roles in pre&#x02013;B and immature B cells to promote immunoglobulin &#x003bb; (<italic>Ig&#x003bb;</italic>) germline transcription as well as <italic>Ig&#x003bb;</italic> VJ gene rearrangement. Furthermore, we show that E12 as well as E47 is required to promote receptor editing upon exposure to self-antigen. We demonstrate that increasing levels of E12 and E47 act to induce <italic>Ig&#x003bb;</italic> germline transcription, promote trimethylated lysine 4 on histone 3 (H3) as well as H3 acetylation across the J&#x003bb; region, and activate <italic>Ig&#x003bb;</italic> VJ gene rearrangement. We propose that in the pre&#x02013;B and immature B cell compartments, gradients of E12 and E47 activities are established to mechanistically regulate the sequential rearrangement of the Ig light chain genes.</p></abstract></article-meta></front><body><p>B cells develop in a multistep process from hematopoietic stem cells (HSCs) and lymphoid-primed multipotent progenitors (LMPPs) into committed B cells that express a B cell receptor (BCR; <xref ref-type="bibr" rid="bib23">Kee and Paige, 1995</xref>; <xref ref-type="bibr" rid="bib19">Hardy et al., 2007</xref>). B cell development has been well characterized mainly based on the developmental stage-specific rearrangement of the Ig heavy chain (<italic>IgH</italic>) and light chain loci (<xref ref-type="bibr" rid="bib3">Alt et al., 1984</xref>; <xref ref-type="bibr" rid="bib8">Cedar and Bergman, 1999</xref>). In pro&#x02013;B cells, <italic>IgH</italic> DJ rearrangement precedes that of VDJ joining. Upon expression of a productive VDJ gene rearrangement, a pre-BCR is formed that acts, in turn, to suppress the expression of the RAG1 and RAG2 proteins, and to promote the survival and proliferation of developing large pre&#x02013;B cells. The proliferation phase is followed by cell-cycle arrest, during which <italic>RAG</italic> gene expression is reinduced to permit Ig light chain gene rearrangement. In the presence of self-reactivity, continued Ig light chain DNA recombination will replace primary <italic>Ig&#x003ba;</italic> VJ joints, ultimately generating BCRs with novel and innocuous specificities (<xref ref-type="bibr" rid="bib40">Radic et al., 1993</xref>; <xref ref-type="bibr" rid="bib50">Tiegs et al., 1993</xref>). Once a BCR has formed that lacks self-reactivity, tonic signaling mediated by the BCR will permanently inhibit <italic>RAG1</italic> and <italic>RAG2</italic> gene expression and promote positive selection. Positively selected B cells migrate to the peripheral lymphoid organs where they, upon interacting with pathogenic determinant, will undergo class switch recombination and somatic hypermutation, and differentiate into plasma or memory B cells (<xref ref-type="bibr" rid="bib14">Gellert, 2002</xref>; <xref ref-type="bibr" rid="bib37">Nemazee, 2006</xref>).</p><p>The specification and commitment of hematopoietic progenitors to the B cell lineage and their maturation into mature B-lineage cells requires the activities of multiple transcription factors, including E2A, early B cell factor (EBF), and Pax5 (<xref ref-type="bibr" rid="bib38">Nutt and Kee, 2007</xref>). The E2A proteins E12 and E47, which arise through alternative splicing of the <italic>Tcfe2a</italic> gene, belong to a subset of helix-loop-helix (HLH) proteins named E proteins. E proteins are transcriptional regulators that contain an HLH dimerization domain, as well as a basic DNA binding region that is located immediately N terminal to the HLH domain. E proteins form homodimers or heterodimers with other E proteins or other members of the HLH family (<xref ref-type="bibr" rid="bib34">Murre, 2005</xref>). These protein complexes have the ability to act either as transcriptional activators or repressors. In vertebrates, four E proteins have been identified. These include the E2A proteins, E12 and E47, which only differ in their basic DNA binding region, as well as HEB and E2-2, both of which give rise to distinct isoforms generated through alternative initiation of transcription (<xref ref-type="bibr" rid="bib9">Corneliussen et al., 1991</xref>; <xref ref-type="bibr" rid="bib52">Wang et al., 2006</xref>). E proteins also have the capacity to interact with antagonistic HLH proteins, named Id proteins. Id proteins contain an HLH domain but lack a basic region, and upon interacting with E proteins, inactivate their DNA binding activity (<xref ref-type="bibr" rid="bib6">Benezra et al., 1990</xref>). E and Id proteins are widely expressed throughout the entire hematopoietic system. They play critical roles at virtually every step of hematopoiesis to promote developmental progression, expansion, and survival of developing lymphocytes (<xref ref-type="bibr" rid="bib27">Lazorchak et al., 2005</xref>; <xref ref-type="bibr" rid="bib34">Murre, 2005</xref>).</p><p>The E2A proteins are active at the HSC cell stage, where they are required for the maintenance of the stem cell pool (<xref ref-type="bibr" rid="bib54">Yang et al., 2008</xref>; <xref ref-type="bibr" rid="bib47">Semerad et al., 2009</xref>). They remain active during the development of HSCs into LMPPs, common lymphoid progenitors (CLPs), and prepro&#x02013;B cells (<xref ref-type="bibr" rid="bib56">Zhuang et al., 2004</xref>; <xref ref-type="bibr" rid="bib7">Borghesi et al., 2005</xref>; <xref ref-type="bibr" rid="bib10">Dias et al., 2008</xref>; <xref ref-type="bibr" rid="bib54">Yang et al., 2008</xref>; <xref ref-type="bibr" rid="bib47">Semerad et al., 2009</xref>). In the absence of E2A, the LMPP and CLP compartments are severely reduced and the pro&#x02013;B cell compartment is completely absent (<xref ref-type="bibr" rid="bib10">Dias et al., 2008</xref>; <xref ref-type="bibr" rid="bib47">Semerad et al., 2009</xref>). In both the LMPP and CLP compartment, the E2A proteins have been postulated to act in concert with other transcriptional regulators, such as PU.1 and Ikaros, to promote further developmental progression (<xref ref-type="bibr" rid="bib48">Singh et al., 2007</xref>; <xref ref-type="bibr" rid="bib38">Nutt and Kee, 2007</xref>).</p><p>B cell development in E2A-ablated mice is arrested at the prepro&#x02013;B cell stage before the onset of <italic>IgH</italic> DJ gene rearrangement (<xref ref-type="bibr" rid="bib4">Bain et al., 1994</xref>; <xref ref-type="bibr" rid="bib55">Zhuang et al., 1994</xref>). A similar block in B cell development is also observed in EBF-deficient mice, and recent data have demonstrated that the E2A proteins act upstream of EBF to promote B-lineage maturation (<xref ref-type="bibr" rid="bib30">Lin and Grosschedl, 1995</xref>; <xref ref-type="bibr" rid="bib20">Ikawa et al., 2004</xref>; <xref ref-type="bibr" rid="bib42">Roessler et al., 2007</xref>). Specifically, forced EBF expression in E2A-deficient bone marrow cells relieves the block at the prepro&#x02013;B cell stage (<xref ref-type="bibr" rid="bib46">Seet et al., 2004</xref>). These data suggest that in the absence of E2A, B lymphopoiesis is blocked before the initiation of B cell development, owing to the inability to activate <italic>Ebf1</italic> transcription in prepro&#x02013;B cells. The E2A proteins are also required to promote a B-lineage program of gene expression in pro&#x02013;B cells, because conditional deletion of <italic>Tcfe2a</italic> revealed that the E2A proteins act to maintain the expression of <italic>Ebf1</italic> and <italic>Pax5</italic> in pro&#x02013;B cells. The block at the prepro&#x02013;B cell stage in E2A-deficient bone marrow is also relieved by the enforced expression of <italic>Pax5</italic>, likely because of the ability of Pax5 to regulate <italic>Ebf</italic>1 expression (<xref ref-type="bibr" rid="bib29">Lazorchak et al., 2006b</xref>; <xref ref-type="bibr" rid="bib25">Kwon et al., 2008</xref>). In addition, multiple pro&#x02013;B cell&#x02013;specific genes contain binding sites for E2A, EBF, and Pax5 in putative promoter and enhancer regions, raising the possibility that the combined activities of E2A, EBF, and Pax5 initiate the B cell fate (<xref ref-type="bibr" rid="bib38">Nutt and Kee, 2007</xref>).</p><p>Upon expression of a pre-BCR, E47 protein levels transiently decline, whereas Id3 levels are elevated (<xref ref-type="bibr" rid="bib45">Schebesta et al., 2002</xref>; <xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>). E12 protein levels have not been studied in detail. At the small pre&#x02013;B cell stage, E47 levels increase again to induce <italic>Ig&#x003ba;</italic> VJ gene rearrangement (<xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>). E47 expression remains high at the immature B cell stage when interaction of the BCR with self-antigen promotes receptor editing (<xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>). During positive selection within the transitional B cell compartments, E47 levels decrease and then decline further at the IgM<sup>+</sup>IgD<sup>+</sup> stage (<xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>; <xref ref-type="bibr" rid="bib25">Kwon et al., 2008</xref>). We have previously proposed a model in which high abundance of E47 enforces the immature B cell checkpoint (<xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>). In the presence of self-reactivity, E47 levels remain high to promote continuous <italic>Ig&#x003ba;</italic> locus accessibility and receptor editing. The expression of an innocuous BCR would lead to a decline of E47 levels, suppressing further Ig light chain recombination and promoting developmental progression toward the mature B cell stage. The E2A proteins initiate <italic>Ig&#x003ba;</italic> VJ gene rearrangement by directly binding to the E-box sites located within the <italic>Ig&#x003ba;</italic> intronic (iE&#x003ba;) and 3&#x02032; enhancers (<xref ref-type="bibr" rid="bib35">Murre et al., 1989</xref>). Mutational analysis of the two E2A binding sites in iE&#x003ba; affects <italic>Ig&#x003ba;</italic> rearrangement as severely as deletion of the entire enhancer, providing unambiguous evidence for a critical function of E-box sites in <italic>Ig&#x003ba;</italic> enhancer function (<xref ref-type="bibr" rid="bib16">Greenbaum and Zhuang, 2002a</xref>; <xref ref-type="bibr" rid="bib21">Inlay et al., 2004</xref>). Enforced expression of E47 or E12 readily promotes <italic>Ig&#x003ba;</italic> locus accessibility to the recombination machinery in nonlymphoid cells, and E2A-deficient pre&#x02013;B cells are defective in their ability to undergo <italic>Ig&#x003ba;</italic> VJ gene rearrangement (<xref ref-type="bibr" rid="bib43">Romanow et al., 2000</xref>; <xref ref-type="bibr" rid="bib15">Goebel et al., 2001</xref>; <xref ref-type="bibr" rid="bib28">Lazorchak et al., 2006a</xref>). Finally, secondary rearrangements and receptor editing are severely impaired in E2A-heterozygous mice (<xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>).</p><p>Because the E2A proteins fulfill fundamental roles in so many aspects of the lymphoid branch of the hematopoietic system, it is important to determine in detail how they exert their unique effects. In particular, although the role of E2A proteins in lymphocyte development is now well established, it is less clear whether E12 and E47 have overlapping and redundant roles or whether they perform distinct functions. Previous studies have described the phenotypes in mice that lack E47 expression (<xref ref-type="bibr" rid="bib5">Bain et al., 1997</xref>). B cell development in E47-ablated mice was blocked at a similar stage as in E2A-deficient mice, although low levels of <italic>Ebf1</italic> and <italic>Pax5</italic> transcripts were detectable (<xref ref-type="bibr" rid="bib5">Bain et al., 1997</xref>). However, because of the applied gene targeting strategy, these mice showed a substantially lower abundance of E12, and it remained unclear whether the defects that were detected were caused by a decrease in E12 and E47 rather than E47 alone (<xref ref-type="bibr" rid="bib5">Bain et al., 1997</xref>).</p><p>To determine the individual roles of E12 and E47 in B cell development, we have generated E12- and E47-deficient mice and analyzed them for abnormalities during B lymphopoiesis. We found that deletion of E47 leads to a block in early B cell development, whereas E12 is dispensable for B cell specification. During later stages of development, however, there is a critical dependence on E12 as well as E47 expression in the pre&#x02013;B and immature B cell compartment. Specifically, using both in vitro and in vivo approaches, we show that E12 and E47 play a crucial role in promoting <italic>Ig&#x003bb;</italic> VJ gene rearrangement and receptor editing. Specifically, we demonstrate that the E2A proteins modulate trimethylated lysine 4 on histone 3 (H3K4me3) across the <italic>Ig&#x003bb;</italic> J regions. These data link E2A, epigenetic marking, and the recruitment of the RAG proteins in a common pathway. Finally, we propose a model in which a gradient of E12 and E47 acts to sequentially regulate <italic>Igk</italic> and <italic>Ig&#x003bb;</italic> VJ gene rearrangement.</p><sec sec-type="results"><title>RESULTS</title><sec><title>Essential role for E47 but not E12 in early B cell development</title><p>To examine the individual roles of E12 and E47 in B cell development, mice were generated that were either deficient in E12 or E47 (<xref ref-type="fig" rid="fig1">Fig. 1 A</xref>). To generate E12<sup>&#x02212;/&#x02212;</sup> and E47<sup>&#x02212;/&#x02212;</sup> mice, exons encoding for either E12 or E47 were flanked with <italic>loxP</italic> sites by homologous recombination in embryonic stem (ES) cells (<xref ref-type="fig" rid="fig1">Fig. 1 A</xref>). Genomic DNA was isolated from targeted ES cells and analyzed by Southern blotting for correct targeting (<xref ref-type="fig" rid="fig1">Fig. 1 B</xref>). Mutant mice were generated from cells carrying the floxed <italic>E12</italic> or <italic>E47</italic> alleles and crossed with transgenic mice that express the Ella-<italic>cre</italic> transgene to delete the <italic>loxP</italic>-flanked DNA regions in the germline (<xref ref-type="bibr" rid="bib26">Lakso et al., 1996</xref>). Mice carrying specific deletions in either <italic>E12</italic> or <italic>E47</italic> were identified using PCR on genomic DNA (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><p><bold>Generation of E12- and E47-deficient mice.</bold> (A) Structure of the targeted <italic>Tcfe2a</italic> locus. The alternatively spliced E12 and E47 exons, respectively, were flanked with loxP sites (indicated by arrows). In addition, a tetracysteine tag (black bar) was inserted into exon 20, 3&#x02032; of the coding region, to produce tagged E47 and E12 proteins. Furthermore, a neomycin (neo) resistance gene was introduced to screen for targeted ES cells. The EcoRI (E) fragments as well as the probe used for screening of the ES cells are indicated. After crossing of <italic>Tcfe2a<sup>fl_E12</sup></italic>- or <italic>Tcfe2a<sup>fl_E47</sup></italic>-bearing mice with a germline Cre-deleter strain (<italic>Ella-Cre</italic>), the corresponding <italic>Tcfe2a<sup>&#x00394;E12</sup></italic> or <italic>Tcfe2a<sup>&#x00394;E47</sup></italic> strains were obtained. (B) Southern blot analysis of EcoRI-digested DNA from correctly targeted ES cells of the indicated genotype. The position of the probe is shown in A. (C) PCR analysis of genomic DNA from mice of the indicated genotype. Primer positions are depicted in A.</p></caption><graphic xlink:href="JEM_20090756_GS_Fig1"/></fig><p>To determine whether E12 and/or E47 is required to promote early B cell development, bone marrow derived from E12<sup>&#x02212;/&#x02212;</sup> and E47<sup>&#x02212;/&#x02212;</sup> mice was examined for cellularity as well as for the presence of B cell markers. In bone marrow and spleen derived from E47<sup>&#x02212;/&#x02212;</sup> mice, B cells were virtually absent (<xref ref-type="fig" rid="fig2">Fig. 2, A and B</xref>). In contrast, the number of B cells in E12<sup>&#x02212;/&#x02212;</sup> mice was not significantly altered as compared with wild-type mice (<xref ref-type="fig" rid="fig2">Fig. 2, A and B</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><p><bold>Essential role for E47 but not E12 in early B cell development.</bold> (A and B) Representative FACS analysis of bone marrow (A) and spleens (B) from wild-type, E47<sup>&#x02212;/&#x02212;</sup>, and E12<sup>&#x02212;/&#x02212;</sup> mice. Numbers indicate percentages of B cells within the live cell fraction. Mean percentages of B cells (B220<sup>+</sup>CD19<sup>+</sup>) in the live cell gate as well as absolute B cell numbers in bone marrow (A) and spleens (B) are depicted. At least four independent experiments using one to three mice per group were performed. Horizontal bars represent the mean. ***, P &#x0003c; 0.001. (C) Flow cytometry of bone marrow B cells from wild-type, E47<sup>&#x02212;/&#x02212;</sup>, and E12<sup>&#x02212;/&#x02212;</sup> mice. Numbers indicate percentages of B cells within the live cell fraction (left) or the B220<sup>+</sup>CD43<sup>+</sup> pro&#x02013;B cell fraction (right). At least four independent experiments using one to three mice per group were performed. (D) Mean percentages of fraction A (HSA<sup>&#x02212;</sup>BP-1<sup>&#x02212;</sup>), fraction B (HSA<sup>+</sup>BP-1<sup>&#x02212;</sup>), and fraction C (HSA<sup>+</sup>BP-1<sup>+</sup>) cells within the pro&#x02013;B cell (B220<sup>+</sup>CD43<sup>+</sup>) compartment of wild-type, E47<sup>&#x02212;/&#x02212;</sup>, and E12<sup>&#x02212;/&#x02212;</sup> mice. At least four independent experiments using one to three mice per group were performed. ns, not significant.</p></caption><graphic xlink:href="JEM_20090756_RGB_Fig2"/></fig><p>Previous studies using E2A<sup>&#x02212;/&#x02212;</sup> mice have revealed that B cell development in these mice is blocked at the prepro&#x02013;B cell stage, because the majority of the cells are arrested in Hardy fraction A (<xref ref-type="bibr" rid="bib5">Bain et al., 1997</xref>). To more precisely determine the arrest in B cell development in E47<sup>&#x02212;/&#x02212;</sup> mice, bone marrow was isolated and analyzed by flow cytometry for the expression of B220, CD43, heat stable antigen (HSA), and BP-1 (<xref ref-type="fig" rid="fig2">Fig. 2 C</xref>; <xref ref-type="bibr" rid="bib18">Hardy and Hayakawa, 2001</xref>). B cell development in E47<sup>&#x02212;/&#x02212;</sup> mice was partially blocked in fraction A and a substantial fraction of cells could be detected in fraction B, whereas virtually no B cells could be detected in fraction C (<xref ref-type="fig" rid="fig2">Fig. 2, C and D</xref>). As expected, the B220<sup>+</sup>c-kit<sup>+</sup> compartment was also severely reduced in E47<sup>&#x02212;/&#x02212;</sup> bone marrow (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">Fig. S1</ext-link>). Interestingly, E12<sup>&#x02212;/&#x02212;</sup> mice showed a slightly higher percentage of fraction C cells among the B220<sup>+</sup>CD43<sup>+</sup> population than wild-type controls (<xref ref-type="fig" rid="fig2">Fig. 2, C and D</xref>).</p><p>To determine whether the excision of the E47 exon affects <italic>E12</italic> mRNA abundance, LMPPs and CLPs were isolated from wild-type and E47<sup>&#x02212;/&#x02212;</sup> bone marrow, and mRNA was isolated and examined for the expression of <italic>E12</italic> by quantitative PCR (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">Fig. S2</ext-link>). Preliminary data show that in both the LMPP and CLP compartment, <italic>E12</italic> levels in the E47-deficient cells were similar to that of their wild-type counterparts (Fig. S2). These data indicate that the block in early B cell development in E47<sup>&#x02212;/&#x02212;</sup> mice is specifically caused by the depletion of E47 expression. Collectively, these data show that E12 does not play a critical role in early B-lineage specification. In contrast, E47 is indispensable at the earliest stages of B cell commitment.</p></sec><sec><title>E12 is required to promote the development of B cells expressing Ig&#x003bb;</title><p>As described in the previous section, B cell development in E12<sup>&#x02212;/&#x02212;</sup> mice seems to be slightly blocked at the transition from Hardy fraction C to the small pre&#x02013;B cell stage, raising the possibility that E12 is required during the small pre&#x02013;B cell stage. To examine this possibility, bone marrow derived from E12<sup>&#x02212;/&#x02212;</sup> mice was analyzed for the abundance of pro&#x02013;B cells (B220<sup>+</sup>IgM<sup>&#x02212;</sup>c-kit<sup>+</sup>), pre&#x02013;B cells (B220<sup>+</sup>IgM<sup>&#x02212;</sup>CD25<sup>+</sup>), immature B cells (B220<sup>intermediate</sup>IgM<sup>+</sup>), and recirculating B cells (B220<sup>hi</sup>IgM<sup>+</sup>) using flow cytometry (<xref ref-type="fig" rid="fig3">Fig. 3 A</xref>). As predicted, the size of the pre&#x02013;B cell compartment was slightly reduced in E12<sup>&#x02212;/&#x02212;</sup> bone marrow (<xref ref-type="fig" rid="fig3">Fig. 3 A</xref>). On the other hand, the pro&#x02013;B, immature B, and mature B cell compartments were not altered in E12<sup>&#x02212;/&#x02212;</sup> bone marrow as compared with wild-type controls (<xref ref-type="fig" rid="fig3">Fig. 3 A</xref>). Similarly, the cellularity of immature B cells (B220<sup>+</sup>IgM<sup>+</sup>IgD<sup>lo</sup>), transitional B cells (B220<sup>+</sup>IgM<sup>+</sup>IgD<sup>+</sup>), mature B cells (B220<sup>+</sup>IgM<sup>lo</sup>IgD<sup>+</sup>), follicular B cells (B220<sup>+</sup>CD23<sup>+</sup>CD21<sup>+</sup>), and marginal zone B cells (B220<sup>+</sup>CD23<sup>&#x02212;</sup>CD21<sup>hi</sup>) in the spleen was similar in E12<sup>&#x02212;/&#x02212;</sup> as compared with wild-type mice (<xref ref-type="fig" rid="fig3">Fig. 3 B</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><p><bold>E12 is required to promote the development of B cells expressing Ig&#x003bb;.</bold> Flow cytometric analysis of B cell populations in wild-type and E12<sup>&#x02212;/&#x02212;</sup> mice. (A) Mean percentages of depicted cell types within the live cell gate and total numbers of pro&#x02013;B cells (B220<sup>+</sup>IgM<sup>&#x02212;</sup>c-kit<sup>+</sup>), pre&#x02013;B cells (B220<sup>+</sup>IgM<sup>&#x02212;</sup>CD25<sup>+</sup>), immature B cells (B220<sup>intermediate</sup>IgM<sup>+</sup>), and recirculating B cells (B220<sup>hi</sup>IgM<sup>+</sup>) in the bone marrow. Six independent experiments using one mouse per group were performed. (B) Mean percentages of depicted cell types within the live cell gate and total numbers of immature B cells (B220<sup>+</sup>IgM<sup>+</sup>IgD<sup>lo</sup>), transitional B cells (B220<sup>+</sup>IgM<sup>+</sup>IgD<sup>+</sup>), mature B cells (B220<sup>+</sup>IgM<sup>lo</sup>IgD<sup>+</sup>), follicular B cells (B220<sup>+</sup>CD23<sup>+</sup>CD21<sup>+</sup>), and marginal zone B cells (B220<sup>+</sup>CD23<sup>&#x02212;</sup>CD21<sup>hi</sup>) in the spleen. Six independent experiments using one mouse per group were performed. (C) Representative FACS analysis of Ig&#x003bb;-expressing B cells in the bone marrow and spleen. Numbers indicate percentages of the depicted gates within the live cell fraction. Nine independent experiments using one mouse per group were performed. (D) Mean percentages and total numbers of newly formed Ig&#x003bb;<sup>+</sup> B cells (B220<sup>intermediate</sup>Ig&#x003bb;<sub>1-3</sub><sup>+</sup>) and recirculating Ig&#x003bb;<sup>+</sup> B cells (B220<sup>hi</sup>Ig&#x003bb;<sub>1-3</sub><sup>+</sup>) in the bone marrow as well as Ig&#x003bb;<sup>+</sup> B cells (B220<sup>+</sup>Ig&#x003bb;<sub>1-3</sub><sup>+</sup>) in the spleen as gated in C. Nine independent experiments using one mouse per group were performed. (E) Percentages of Ig&#x003ba;<sup>+</sup> cells within the B220<sup>+</sup> fraction as well as the ratio of Ig&#x003ba;<sup>+</sup> to Ig&#x003bb;<sup>+</sup> B cells in the bone marrow (left) and spleen (right). Six independent experiments using one mouse per group were performed. All bar graphs show means &#x000b1; SEM. **, P &#x02264; 0.01; ***, P &#x0003c; 0.001 (values are not significantly different from wild-type controls if there is no p-value depicted).</p></caption><graphic xlink:href="JEM_20090756_RGB_Fig3"/></fig><p>Previous studies demonstrated a critical role for the E2A proteins in receptor editing (<xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>). Furthermore, a substantial reduction in the fraction of Ig&#x003bb;-expressing cells was observed in E2A<sup>+/&#x02212;</sup> mice. To determine whether E12 plays a critical role in the development and/or survival of Ig&#x003bb;-expressing cells, E12<sup>&#x02212;/&#x02212;</sup> bone marrow was analyzed for the presence of Ig&#x003bb;<sub>1-3</sub><sup>+</sup> cells by flow cytometry. Strikingly, the fraction of Ig&#x003bb;-expressing B cells was substantially reduced in E12<sup>&#x02212;/&#x02212;</sup> mice as compared with those of wild-type littermates (<xref ref-type="fig" rid="fig3">Fig. 3, C and D</xref>). Similarly, total numbers of Ig&#x003bb;<sup>+</sup> cells in the bone marrow of E12<sup>&#x02212;/&#x02212;</sup> mice were significantly reduced as compared with those of wild-type mice (<xref ref-type="fig" rid="fig3">Fig. 3 D</xref>). Comparable reductions were observed among newly formed B220<sup>intermediate</sup> and recirculating B220<sup>hi</sup> bone marrow B cells as well as in splenic B cells (<xref ref-type="fig" rid="fig3">Fig. 3, C and D</xref>). In contrast, the fraction of Ig&#x003ba;-expressing cells was slightly elevated in the bone marrow as well as in the spleen of E12<sup>&#x02212;/&#x02212;</sup> mice, resulting in a much higher Ig&#x003ba;/Ig&#x003bb; ratio in E12<sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="fig3">Fig. 3 E</xref>). In summary, these data show that E12 plays a distinct and essential role in the developmental progression and/or survival of B cells that express Ig&#x003bb;.</p></sec><sec><title>Defective receptor editing in E12<sup>&#x02212;/&#x02212;</sup> mice</title><p>The aforementioned data show that the Ig&#x003ba;/Ig&#x003bb; ratio was severely perturbed in E12<sup>&#x02212;/&#x02212;</sup> B cells, raising the possibility that E12 plays a critical role in promoting <italic>Ig&#x003bb;</italic> VJ gene rearrangement upon exposure to self-antigen. To determine whether E12 plays a role in promoting receptor editing, bone marrow cells were isolated from wild-type and E12<sup>&#x02212;/&#x02212;</sup> mice and transplanted into recipients that constitutively express a &#x003ba;-macroself transgene (<xref ref-type="bibr" rid="bib2">Ait-Azzouzene et al., 2005</xref>). 6 wk after transplantation, bone marrow as well as spleen cells were harvested and examined for the expression of Ig&#x003bb;, Ig&#x003ba;, and B220 (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">Fig. S3</ext-link>). As shown previously, the bone marrow of recipients expressing the &#x003ba;-macroself transgene that received wild-type cells showed an increased frequency of Ig&#x003bb;<sup>+</sup> B cells as compared with recipients that lacked &#x003ba;-macroself expression (Fig. S3 B). Similarly our preliminary results show that mice that received E12<sup>&#x02212;/&#x02212;</sup> bone marrow cells also have increased percentages of Ig&#x003bb;<sup>+</sup> cells if recipients expressed the &#x003ba;-macroself transgene as compared with nontransgenic control recipients (Fig. S3 B). This increase in Ig&#x003bb;-expressing cells was similar or even greater in the absence as compared with the presence of E12. However, the fraction of Ig&#x003bb;-expressing cells in &#x003ba;-macroself recipients reconstituted with E12<sup>&#x02212;/&#x02212;</sup> cells was significantly lower as compared with those reconstituted with bone marrow cells from wild-type littermate controls (Fig. S3, A and B).</p><p>As expected, tolerance was maintained because no Ig&#x003ba;-expressing cells were detectable in the spleen of recipients expressing the &#x003ba;-macroself antigen transplanted with either wild-type or E12<sup>&#x02212;/&#x02212;</sup> bone marrow (Fig. S3 C, bottom). The fraction of Ig&#x003bb;-expressing cells in the spleens of recipients that express the &#x003ba;-macroself transgene was significantly lower in E12<sup>&#x02212;/&#x02212;</sup> bone marrow as compared with wild-type chimeras (Fig. S3, C and D, top). Furthermore, the overall decrease in the total number of splenic B cells was much more substantial in E12<sup>&#x02212;/&#x02212;</sup> chimeras as compared with controls (Fig. S3 D, bottom). Collectively, these data indicate that upon exposure to self-antigen, the induction of receptor editing does not fully require E12 activity; however, E12 critically modulates the magnitude of the Ig&#x003bb; response.</p></sec><sec><title>E47 and E12 abundance is limiting during the development of Ig&#x003bb;-expressing B cells</title><p>The observations described in the previous section demonstrate that E12 plays a critical role in the developmental progression of Ig&#x003bb;-expressing cells upon exposure to self-antigen. Because B cell development in E47<sup>&#x02212;/&#x02212;</sup> mice was blocked at the Hardy fraction A/B cell stage, we were not able to assess how the complete absence of E47 affects the developmental progression of B cells beyond the pro&#x02013;B cell stage. To address this issue and to compare the individual roles of E12 and E47 at the pre&#x02013;B and immature B cell stage, we examined E12<sup>+/&#x02212;</sup> and E47<sup>+/&#x02212;</sup> mice for the abundance of Ig&#x003bb;-expressing cells. Bone marrow cells derived from wild-type, E12<sup>+/&#x02212;</sup>, E47<sup>+/&#x02212;</sup>, and E12<sup>&#x02212;/&#x02212;</sup> mice were isolated and examined for the expression of Ig&#x003bb;. Both E12<sup>+/&#x02212;</sup> and E47<sup>+/&#x02212;</sup> mice showed a substantial reduction in the fraction of Ig&#x003bb;<sub>1-3</sub><sup>+</sup> B cells (<xref ref-type="fig" rid="fig4">Fig. 4, A and B</xref>). Similarly, the fraction of Ig&#x003bb;-expressing cells in the spleen derived from E12<sup>+/&#x02212;</sup> and E47<sup>+/&#x02212;</sup> mice was significantly reduced as compared to wild-type mice (<xref ref-type="fig" rid="fig4">Fig. 4 C</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><p><bold>E47 and E12 abundance is limiting during the development of Ig&#x003bb;-expressing B cells.</bold> (A&#x02013;C) Mean percentages and total numbers of newly formed Ig&#x003bb;<sup>+</sup> B cells (B220<sup>intermediate</sup>Ig&#x003bb;<sub>1-3</sub><sup>+</sup>; A) and recirculating Ig&#x003bb;<sup>+</sup> B cells (B220<sup>hi</sup>Ig&#x003bb;<sub>1-3</sub><sup>+</sup>; B) in the bone marrow as well as Ig&#x003bb;<sup>+</sup> B cells (B220<sup>+</sup>Ig&#x003bb;<sub>1-3</sub><sup>+</sup>; C) in the spleen as gated in <xref ref-type="fig" rid="fig3">Fig. 3 C</xref> from mice of the indicated genotypes. At least three independent experiments using one mouse per group were performed. (D) Quantitative PCR analysis of <italic>E12</italic> and <italic>E47</italic> transcripts in FACS-sorted pre&#x02013;B cells (B220<sup>+</sup>IgM<sup>&#x02212;</sup>CD25<sup>+</sup>) from the bone marrow of wild-type, E12<sup>+/&#x02212;</sup>, E47<sup>+/&#x02212;</sup>, and E12<sup>&#x02212;/&#x02212;</sup> mice. Levels were normalized to hypoxanthine guanine phosphoribosyl transferase 1 (<italic>Hprt1</italic>) transcripts and relative levels to wild-type controls are shown (2<sup>&#x02212;&#x00394;&#x00394;Ct</sup>). Bar graphs show means &#x000b1; SEM of three independent experiments. *, P &#x02264; 0.05; **, P &#x02264; 0.01; ***, P &#x0003c; 0.001 (values are not significantly different from wild-type controls if there is no p-value depicted). nd, not detectable.</p></caption><graphic xlink:href="JEM_20090756R_GS_Fig4"/></fig><p>Although the E12 and E47 exons were specifically excised in the null mutant mice, it remained possible that E12 and E47 cross-regulate each other. To explore this possibility, we isolated mRNA from sorted pre&#x02013;B cells derived from wild-type, E12<sup>+/&#x02212;</sup>, E47<sup>+/&#x02212;</sup>, or E12<sup>&#x02212;/&#x02212;</sup> mice and determined the mRNA levels of <italic>E12</italic> and <italic>E47</italic> by quantitative PCR (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref>). Pre&#x02013;B cells derived from E47<sup>+/&#x02212;</sup> showed slightly elevated levels of <italic>E12</italic> mRNA (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref>, left). In contrast, <italic>E47</italic> levels in E12<sup>+/&#x02212;</sup> pre&#x02013;B cells were not significantly altered (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref>, right). E12<sup>&#x02212;/&#x02212;</sup> pre&#x02013;B cells, on the other hand, showed a modest reduction in <italic>E47</italic> levels (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref>, right). These data indicate that <italic>E47</italic> levels are modestly but significantly reduced in E12<sup>&#x02212;/&#x02212;</sup> pre&#x02013;B cells. On the other hand, <italic>E47</italic> abundance is not significantly affected in E12<sup>+/&#x02212;</sup> pre&#x02013;B cells. Furthermore, these data indicate that depletion of E47 slightly but significantly elevates the expression of <italic>E12</italic>. Thus the defect in Ig&#x003bb;-expressing cells in E47<sup>+/&#x02212;</sup> and E12<sup>+/&#x02212;</sup> mice cannot be explained by abnormalities in the abundance of either E12 or E47. Collectively, these data demonstrate that both E12 and E47 play a critical role in the developmental progression of Ig&#x003bb;-expressing B cells.</p></sec><sec><title>E12 and E47 facilitate <italic>Ig&#x003bb;</italic> locus accessibility</title><p>Given that Ig&#x003bb;-expressing cells were less abundant in E12<sup>+/&#x02212;</sup>, E47<sup>+/&#x02212;</sup>, and E12<sup>&#x02212;/&#x02212;</sup> mice, we considered the possibility that E12 proteins act to regulate <italic>Ig&#x003bb;</italic> VJ gene rearrangement. To address this issue, DNA was isolated from sorted pre&#x02013;B cells derived from wild-type, E12<sup>+/&#x02212;</sup>, E47<sup>+/&#x02212;</sup>, and E12<sup>&#x02212;/&#x02212;</sup> mice and analyzed by semiquantitative PCR for the presence of <italic>IgH</italic> DJ as well as <italic>Ig&#x003ba;</italic> and <italic>Ig&#x003bb;</italic> VJ gene rearrangements. <italic>IgH</italic> DJ and <italic>Ig&#x003ba;</italic> VJ joining is not perturbed in pre&#x02013;B cells isolated from E47<sup>+/&#x02212;</sup>, E12<sup>+/&#x02212;</sup>, and E12<sup>&#x02212;/&#x02212;</sup> mice (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">Fig. S4</ext-link>). Recombining sequence (RS) rearrangements were only modestly affected in E12<sup>+/&#x02212;</sup>, E47<sup>+/&#x02212;</sup>, and E12<sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="fig5">Fig. 5 B</xref>, left and middle). In contrast, <italic>Ig&#x003bb;</italic> V1-J1 rearrangement was significantly reduced in pre&#x02013;B cells isolated from both E12<sup>+/&#x02212;</sup> and E47<sup>+/&#x02212;</sup> mice (<xref ref-type="fig" rid="fig5">Fig. 5 B</xref>, right). As predicted, E12<sup>&#x02212;/&#x02212;</sup> pre&#x02013;B cells showed a significant decrease in the levels of <italic>Ig&#x003bb;</italic> VJ gene rearrangements as compared with wild-type mice and, importantly, also with E47<sup>+/&#x02212;</sup> pre&#x02013;B cells (<xref ref-type="fig" rid="fig5">Fig. 5 B</xref>, right). These data indicate that both E12 and E47 act to promote <italic>Ig&#x003bb;</italic> VJ gene rearrangement.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><p><bold>E12 and E47 facilitate <italic>Ig&#x003bb;</italic> locus accessibility.</bold> (A) Schematic diagram of the mouse <italic>IgH</italic> and light chain (<italic>Ig&#x003ba;</italic> and <italic>Ig&#x003bb;</italic>) loci. V, D, J, and C segments as well as the RS in <italic>Ig&#x003ba;</italic> are depicted as gray boxes and the enhancers are depicted as white boxes. Analyzed gene rearrangements are shown by arrows on top of the loci, whereas germline transcripts are shown by arrows under the gene locus. (B) Quantification of Southern blots from PCR analysis of Ig gene rearrangements in FACS-sorted pre&#x02013;B cells (B220<sup>+</sup>IgM<sup>&#x02212;</sup>CD25<sup>+</sup>) from mice of the indicated genotypes. PCR products from reactions of fourfold serial dilutions were electrophoresed on agarose gels and abundance was quantitated by Southern blotting using specific probes. Shown are means &#x000b1; SEM relative to wild-type signal. *, P &#x02264; 0.05; ***, P &#x0003c; 0.001 (values are not significantly different from wild-type controls if there is no p-value depicted). Three independent experiments using one mouse per group were performed. (C) Quantitative PCR analysis of <italic>Ig&#x003bb;1</italic> germline transcripts (<italic>Ig&#x003bb;1&#x000b0;</italic>) in FACS-sorted pre&#x02013;B cells (B220<sup>+</sup>IgM<sup>&#x02212;</sup>CD25<sup>+</sup>) from the bone marrow of wild-type, E12<sup>+/&#x02212;</sup>, E47<sup>+/&#x02212;</sup>, and E12<sup>&#x02212;/&#x02212;</sup> mice. Levels were normalized to <italic>Hprt1</italic> transcripts and relative levels to wild-type controls are shown (2<sup>&#x02212;&#x00394;&#x00394;Ct</sup>). Shown are means &#x000b1; SEM. *, P &#x02264; 0.05; **, P &#x02264; 0.01; ***, P &#x0003c; 0.001 (values are not significantly different from wild-type controls if there is no p-value depicted). Three independent experiments using one mouse per group were performed. (D) ChIP assays using anti-E2A antibodies on MACS-purified total B220<sup>+</sup> bone marrow cells from wild-type and E12<sup>&#x02212;/&#x02212;</sup> mice. Relative enrichment of the bound DNA over input was determined by quantitative PCR using specific primers for the Ig&#x003bb; enhancers E&#x003bb;<sub>1-3</sub> and E&#x003bb;<sub>2-4</sub>. Shown are means &#x000b1; SEM. Two independent experiments using one mouse per group were performed. IRS1, intronic recombination sequence 1.</p></caption><graphic xlink:href="JEM_20090756_GS_Fig5"/></fig><p>To determine whether the decrease in <italic>Ig&#x003bb;</italic> VJ gene rearrangements in E12<sup>+/&#x02212;</sup> and E47<sup>+/&#x02212;</sup> bone marrow cells was caused by lower levels of <italic>RAG1</italic> and/or <italic>RAG2</italic> expression, mRNA was isolated from sorted pre&#x02013;B cells and examined by quantitative PCR for the expression of <italic>RAG1/2</italic>. Both <italic>RAG1</italic> and <italic>RAG2</italic> mRNA levels were not significantly altered in E12<sup>+/&#x02212;</sup> and E47<sup>+/&#x02212;</sup> as compared with wild-type mice (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">Fig. S5</ext-link>). To determine whether a reduction in E12 and/or E47 affected <italic>Ig&#x003bb;</italic> germline transcription, mRNA from sorted pre&#x02013;B cells was analyzed for the expression of <italic>Ig&#x003bb;1</italic> germline transcripts. Consistent with the decrease in <italic>Ig&#x003bb;</italic> VJ gene rearrangements in E12<sup>+/&#x02212;</sup> and E47<sup>+/&#x02212;</sup> pre&#x02013;B cells, <italic>Ig&#x003bb;1</italic> germline transcript levels were significantly reduced as compared with wild-type (<xref ref-type="fig" rid="fig5">Fig. 5 C</xref>). As expected, a further reduction in <italic>Ig&#x003bb;</italic> germline transcription was observed in E12<sup>&#x02212;/&#x02212;</sup> pre&#x02013;B cells (<xref ref-type="fig" rid="fig5">Fig. 5 C</xref>). Collectively, these data suggest that E12 and E47 activate <italic>Ig&#x003bb;</italic> VJ gene rearrangement by modulating <italic>Ig&#x003bb;</italic> locus accessibility to the recombination machinery.</p><p>Consistent with a role for E12 and E47 in modulating <italic>Ig&#x003bb;</italic> locus accessibility are previous observations indicating the presence of E12 and E47 binding sites in the <italic>Ig&#x003bb;</italic> enhancer regions (<xref ref-type="bibr" rid="bib44">Rudin and Storb, 1992</xref>). To determine whether E12 and E47 directly interact with E-box sites present in the <italic>Ig&#x003bb;</italic> enhancer, B cells were isolated from wild-type and E12<sup>&#x02212;/&#x02212;</sup> bone marrow, cross-linked with formaldehyde, and immunoprecipitated with an anti-E2A antibody. Subsequently, DNA was isolated from the immunoprecipitates and examined for the presence of regions containing E&#x003bb;<sub>1-3</sub> and E&#x003bb;<sub>2-4</sub> using the appropriate primers. Both E12 and E47 interacted with the <italic>Ig&#x003bb;</italic> enhancer regions, E&#x003bb;<sub>1-3</sub> and E&#x003bb;<sub>2-4</sub>, because the enrichment observed in wild-type bone marrow cells was severely reduced in E12<sup>&#x02212;/&#x02212;</sup> cells but not abolished (<xref ref-type="fig" rid="fig5">Fig. 5 D</xref>). Thus, we conclude that the residual binding to the <italic>Ig&#x003bb;</italic> enhancer regions is caused by E47 (<xref ref-type="fig" rid="fig5">Fig. 5 D</xref>). Collectively, these data demonstrate that both E12 and E47 interact with E-box sites present in the <italic>Ig&#x003bb;</italic> enhancers, activate <italic>Ig&#x003bb;</italic> germline transcription, modulate <italic>Ig&#x003bb;</italic> locus accessibility, and promote <italic>Ig&#x003bb;</italic> VJ gene rearrangement.</p></sec><sec><title>Attenuation of IL-7 signaling elevates E12 and E47 abundance</title><p>Previous observations have indicated that E47 abundance is low in cycling large pre&#x02013;B cells but is elevated in small resting pre&#x02013;B cells (<xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>). Because Ig light chain gene rearrangement is initiated by pre-BCR signaling as well as attenuation of IL-7 signaling, we examined the temporal expression of E12 and E47 in bone marrow cells that express an innocuous BCR upon withdrawal of IL-7 signaling. In brief, B cells expressing the hen egg lysozyme transgene (HEL-Tg) were isolated from the bone marrow and grown for a period of 4 d in the presence of IL-7. Upon withdrawal of IL-7 from the B cell cultures, the abundance of <italic>Ig&#x003bb;</italic> germline transcripts as well as <italic>E12</italic> and <italic>E47</italic> transcript levels were determined at various time points using quantitative PCR. Upon attenuation of IL-7&#x02013;mediated signaling, <italic>E12</italic> and <italic>E47</italic> transcript levels increased gradually (<xref ref-type="fig" rid="fig6">Fig. 6 A</xref>). Interestingly, the relative increase in <italic>E12</italic> expression was modestly but consistently larger than that of <italic>E47</italic> expression, with the ratio of <italic>E12</italic> to <italic>E47</italic> expression increasing over time (<xref ref-type="fig" rid="fig6">Fig. 6 A</xref>). Concomitant with the increase in <italic>E12</italic> and <italic>E47</italic> mRNA levels, we observed an increase in <italic>Ig&#x003bb;</italic> germline transcription consistent with a model in which E12 directly regulates <italic>Ig&#x003bb;</italic> germline transcription (<xref ref-type="fig" rid="fig6">Fig. 6 B</xref>). To determine whether E12 is required for the induction of <italic>Ig&#x003bb;</italic> germline transcription, E12<sup>+/+</sup>, HEL-Tg and E12<sup>+/&#x02212;</sup>, HEL-Tg bone marrow cells were cultured in the presence of IL-7 for 4 d, followed by withdrawal of IL-7. RNA was isolated at the indicated time points and examined for the presence of <italic>Ig&#x003bb;</italic> germline transcription. Consistent with these observations, <italic>Ig&#x003bb;</italic> germline transcript levels were significantly reduced in E12<sup>+/&#x02212;</sup> immature B cells (<xref ref-type="fig" rid="fig6">Fig. 6 B</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><p><bold>Attenuation of IL-7 signaling elevates E12 and E47 abundance.</bold> (A) Quantitative PCR analysis of <italic>E47</italic> and <italic>E12</italic> transcripts at various time points after IL-7 withdrawal from cell cultures of HEL-Tg B cells. Levels were normalized to <italic>Hprt1</italic> transcripts, and expression levels relative to before IL-7 withdrawal are determined (2<sup>&#x02212;&#x00394;&#x00394;Ct</sup>). Shown are means &#x000b1; SEM of three independent experiments. (B) Quantitative PCR analysis of <italic>Ig&#x003bb;1</italic> germline transcripts at various time points after IL-7 withdrawal from B cell cultures generated from the bone marrow of HEL-Tg and E12<sup>+/&#x02212;</sup>, HEL-Tg mice. Levels were normalized to <italic>Hprt1</italic> transcripts and relative expression levels are determined (2<sup>&#x02212;&#x00394;Ct</sup>). Shown are means &#x000b1; SEM of three independent experiments.</p></caption><graphic xlink:href="JEM_20090756_GS_Fig6"/></fig></sec><sec><title>E2A proteins modulate epigenetic marks across the Ig&#x003bb; J regions</title><p>Intriguing studies have recently indicated a correlation between epigenetic marking and antigen receptor assembly. Specifically, a noncanonical plant homeodomain located within the noncore region of RAG2 was shown to interact with H3K4me3 (<xref ref-type="bibr" rid="bib31">Liu et al., 2007</xref>; <xref ref-type="bibr" rid="bib33">Matthews et al., 2007</xref>; <xref ref-type="bibr" rid="bib41">Ram&#x000f3;n-Maiques et al., 2007</xref>). Furthermore, across the J<italic>&#x003bb;</italic> region, H3K4me3 and H3 acetylation (H3ac) were shown to be specifically enriched during the pre&#x02013;B and immature B cell stages (<xref ref-type="bibr" rid="bib53">Xu and Feeney, 2009</xref>). These observations raise the possibility that the E2A proteins regulate <italic>Ig&#x003bb;</italic> VJ gene rearrangement by promoting the recruitment of RAG2 to the recombination signal sequences by, directly or indirectly, modulating trimethylation of H3K4. To address this issue, B220<sup>+</sup> bone marrow cells from wild-type and E12<sup>&#x02212;/&#x02212;</sup> mice were cultured in the presence of IL-7 and stem cell factor for 8 d to obtain a homogeneous culture of B220<sup>+</sup>CD19<sup>+</sup>CD43<sup>+</sup> pro&#x02013;B cells. After IL-7 withdrawal for 18 h, we examined the J<italic>&#x003bb;</italic> region for H3K4 trimethylation as well as H3ac by chromatin immunoprecipitation (ChIP; <xref ref-type="fig" rid="fig7">Fig. 7, A and B</xref>). Interestingly, both H3K4me3 and H3ac across the J<italic>&#x003bb;</italic> region were significantly reduced in the absence of E12 (<xref ref-type="fig" rid="fig7">Fig. 7, A and B</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><p><bold>E2A modulates the abundance of H3K4me3 across the Ig&#x003bb; J regions.</bold> (A and B) ChIP assays using anti-H3K4me3 (A) or anti-H3ac (B) antibodies on pro&#x02013;B cell cultures from wild-type and E12<sup>&#x02212;/&#x02212;</sup> mice that were deprived of IL-7 for 18 h. Relative enrichment of the bound DNA over input was determined by quantitative PCR using specific primers for the Ig&#x003bb; J1 region. Shown are means &#x000b1; SEM of two independent experiments. *, P &#x02264; 0.05; **, P &#x02264; 0.01.</p></caption><graphic xlink:href="JEM_20090756_GS_Fig7"/></fig><p>Collectively, these data indicate that E12 expression is elevated in immature B cells to initiate <italic>Ig&#x003bb;</italic> germline transcription and to promote <italic>Ig&#x003bb;</italic> locus accessibility. Based on these, as well as previous observations, we propose that in immature B cells initially, E12 and E47 abundance is low, preventing accessibility of the <italic>Ig&#x003bb;</italic> locus to the recombination machinery. However, increasing levels of E12 and E47 would eventually lead to relative high occupancy of E-box elements present in the <italic>Ig&#x003bb;</italic> enhancer, inducing <italic>Ig&#x003bb;</italic> germline transcription and permitting the activation of <italic>Ig&#x003bb;</italic> VJ gene rearrangement (<xref ref-type="fig" rid="fig8">Fig. 8</xref>). Furthermore, we suggest that the E2A proteins act to promote epigenetic marking of histone residues located at the J&#x003bb; regions to permit the recruitment of RAG2 to the recombination machinery.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><p><bold>A gradient of E12 and E47 activity leads to the sequential activation of the <italic>Ig</italic> light chains.</bold> Attenuation of IL-7 signaling leads to an increase in E12 and E47 expression to initiate Ig light chain gene rearrangement. Signaling through a functional BCR suppresses E12/E47 expression to prevent further rearrangements and promote positive selection and maturation. However, in the absence of such a signal, the ratio of E12 to E47 reaches a certain threshold, which enables the cell to rearrange the <italic>Ig&#x003bb;</italic> loci. Failure to generate a functional BCR during a certain time window will lead to cell death, presumably caused by high E12 and E47 levels.</p></caption><graphic xlink:href="JEM_20090756_GS_Fig8"/></fig></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The <italic>Tcfe2a</italic> locus encodes for two highly related proteins that differ in their DNA binding region through alternative splicing of one exon (<xref ref-type="bibr" rid="bib35">Murre et al., 1989</xref>; <xref ref-type="bibr" rid="bib49">Sun and Baltimore, 1991</xref>). From previous studies, it is apparent that the transcription factor E2A is not only indispensable for commitment to the B cell lineage but fulfills critical functions throughout B lymphopoiesis that include maintenance, DNA recombination, receptor editing, marginal versus follicular zone development, and class switch recombination (<xref ref-type="bibr" rid="bib17">Greenbaum and Zhuang, 2002b</xref>; <xref ref-type="bibr" rid="bib34">Murre, 2005</xref>). We have previously generated E47-deficient mice that also showed substantially reduced abundance of E12 caused by the insertion of the neomycin gene. Thus, an important unresolved question is whether E12 and E47 fulfill distinct and/or overlapping roles during B lymphopoiesis. In this study, we have generated two mouse strains that selectively delete either the E12 or the E47 exon through the usage of the loxP system, enabling us to study their specific roles during B cell development.</p><p>Previous studies have shown that B cell development in E2A-deficient mice is completely blocked at the prepro&#x02013;B cell stage (<xref ref-type="bibr" rid="bib4">Bain et al., 1994</xref>; <xref ref-type="bibr" rid="bib55">Zhuang et al., 1994</xref>). Overexpression of either E12 or E47 has the ability of triggering commitment to the B cell lineage, raising the possibility that both play a role in B cell specification and/or commitment (<xref ref-type="bibr" rid="bib5">Bain et al., 1997</xref>). Our study shows that E47 is strictly required for progression beyond the prepro&#x02013;B cell stage and that endogenous levels of E12 cannot compensate for its loss. In striking contrast, E12-deficient mice show almost normal numbers of mature B cells in the bone marrow and spleen. However, the pre&#x02013;B cell compartment is slightly reduced in E12-deficient bone marrow. We note that the decrease in the pre&#x02013;B cell compartment of E12-deficient bone marrow might be caused by the twofold decrease in <italic>E47</italic> mRNA levels (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref>). Thus, in the presence of endogenous levels of E47 protein, E12 is dispensable for the specification of the B cell fate. In turn, this suggests that E47 but not E12 activates a B lineage&#x02013;specific program of gene expression.</p><p>In addition to regulating lineage decisions through the activation of gene expression of B cell&#x02013;specific genes, the E2A proteins also play critical roles in regulating Ig gene rearrangements. Both E47 as well as E12 were originally identified as factors that interact with the &#x003ba;E2 site of the iE&#x003ba;. Deletion of the two E-boxes in iE&#x003ba; affects <italic>Ig&#x003ba;</italic> recombination to the same degree as deletion of the complete enhancer (<xref ref-type="bibr" rid="bib35">Murre et al., 1989</xref>; <xref ref-type="bibr" rid="bib21">Inlay et al., 2004</xref>). Forced E12 or E47 expression, in conjunction with RAG1 and RAG2, promotes <italic>Ig&#x003ba;</italic> VJ gene rearrangement in nonlymphoid cells (<xref ref-type="bibr" rid="bib43">Romanow et al., 2000</xref>). Furthermore, <italic>Ig&#x003ba;</italic> VJ gene rearrangements in E2A-deficient pre&#x02013;B cells are completely abolished (<xref ref-type="bibr" rid="bib29">Lazorchak et al., 2006b</xref>; <xref ref-type="bibr" rid="bib25">Kwon et al., 2008</xref>).</p><p>Collectively, these studies establish the E2A proteins as key regulators of <italic>Ig&#x003ba;</italic> VJ gene rearrangement. We show in this study, however, that <italic>Ig&#x003ba;</italic> VJ gene rearrangement is not affected in E12-deficient mice. Because B cell development in E47-deficient mice is completely blocked at the prepro&#x02013;B cell stage and because we were not able to generate E47<sup>F/F</sup> mice that would permit the stage-specific deletion at the pre&#x02013;B or immature B cell stage, we could not assess directly whether E47 is the critical component in promoting <italic>Ig&#x003ba;</italic> VJ DNA recombination. However, because E2A-deficient B cells are completely defective in <italic>Ig&#x003ba;</italic> VJ recombination and E12 activity is not required, we infer that E47 is the main factor required to promote <italic>Ig&#x003ba;</italic> VJ joining.</p><p>In contrast, we show in this study that both E47 and E12 are required for proper <italic>Ig&#x003bb;</italic> gene rearrangement. As described, E12-deficient B cells show a reduction in <italic>E47</italic> mRNA levels that is similar to that observed in B cells from E47-heterozygous mice. Because E47-heterozygous B cells also have a significant defect in <italic>Ig&#x003bb;</italic> VJ gene rearrangement, E12-deficient B cells cannot be used to evaluate the role of E12 in <italic>Ig&#x003bb;</italic> VJ gene rearrangement. Therefore, E12-heterozygous B cells that show normal levels of E47 were used to unambiguously demonstrate a critical role for E12 in <italic>Ig&#x003bb;</italic> VJ gene rearrangement. We emphasize, however, that in addition to E12, E47 also plays a critical role in modulating <italic>Ig&#x003bb;</italic> VJ gene rearrangement.</p><p>There are several mechanisms that may underpin the decrease in Ig&#x003bb;-expressing cells in E12- or E47-deficient pre&#x02013;B cells. First, it is conceivable that E12 and E47 act to promote the survival and/or life span of immature B cells, because previous studies have demonstrated a critical role for the E proteins in B cell survival (<xref ref-type="bibr" rid="bib24">Kee et al., 2002</xref>; <xref ref-type="bibr" rid="bib29">Lazorchak et al., 2006b</xref>). In this case, however, survival of in vitro&#x02013;cultured E12<sup>+/&#x02212;</sup> B cells expressing the HEL-Tg is not affected, yet they do not efficiently up-regulate <italic>Ig&#x003bb;</italic> germline transcripts. Thus, although we cannot exclude the possibility that the E2A proteins act, in part, to promote cell survival at the immature B cell stage in vivo<italic>,</italic> we consider it unlikely that this is their sole function. A second possibility is that RS deletion is regulated by E12 and E47. RS is a DNA element that carries a canonical recombination signal sequence. It is located &#x0223c;25 kbp downstream of the <italic>Ig&#x003ba;</italic> constant region and rearranges by DNA recombination to V&#x003ba; elements and to elements present in the J&#x003ba;-C&#x003ba; intronic region. The absence of RS deletion substantially interferes with the development of Ig&#x003bb;-producing cells (<xref ref-type="bibr" rid="bib51">Vela et al., 2008</xref>). Thus, it is conceivable that Ig&#x003bb; production in E12-ablated bone marrow cells is perturbed because of a reduction in RS deletion. However, in this study we show that RS deletion is only modestly affected in E12-deficient pre&#x02013;B and immature B cells carrying unmanipulated BCRs. A third possibility is that E12 and E47 are required to activate the expression of <italic>RAG1</italic>/<italic>2</italic>. However, E12- and E47-heterozygous pre&#x02013;B cells did not show decreased levels of either <italic>RAG1</italic> or <italic>RAG2</italic> mRNA. A fourth possibility, and one that we favor, is that E12 and E47 binding to the <italic>Ig&#x003bb;</italic> enhancers directly allows the recombinase access to the recombination signal sequences.</p><p>It is now well established that the Ig light chain loci rearrange sequentially. Specifically, <italic>Ig&#x003ba;</italic> VJ rearrangements are initiated before the onset of <italic>Ig&#x003bb;</italic> VJ gene rearrangement (<xref ref-type="bibr" rid="bib36">Nadel et al., 1990</xref>; <xref ref-type="bibr" rid="bib12">Engel et al., 1999</xref>). It has remained unclear how the sequential rearrangement of the Ig light chain genes is achieved during the developmental progression of B-lineage cells. We suggest that E12 and E47 are critical players that regulate the sequential activation of <italic>Ig&#x003ba;</italic> versus <italic>Ig&#x003bb;</italic> loci. Previous observations have demonstrated that E47 abundance in large cycling pre&#x02013;B cells is low but elevated during the transition toward the small pre&#x02013;B cell stage (<xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>). We also have previously proposed that at the pre&#x02013;B cell stage, concurrent with the cessation of proliferation, E2A levels are elevated to initiate <italic>Ig&#x003ba;</italic> VJ gene rearrangement (<xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>). In this study, we show that attenuation of IL-7 signaling elevates both <italic>E12</italic> and <italic>E47</italic> expression. We speculate that once pre&#x02013;B cells migrate away from IL-7&#x02013;expressing stroma, E47 as well as E12 levels increase to establish a gradient of E2A activity. This gradient of E2A activity promotes the sequential activation of <italic>Ig&#x003ba;</italic> versus <italic>Ig&#x003bb;</italic> VJ gene rearrangement. In such a model, relatively low levels of E47 would be sufficient to bind the E-box sites present in the <italic>Ig&#x003ba;</italic> enhancer and to promote <italic>Ig&#x003ba;</italic> locus accessibility. Initial levels of E47 are sufficient to achieve high occupancy binding to E-box sites present in the <italic>Ig&#x003ba;</italic> but not the <italic>Ig&#x003bb;</italic> locus. The differences in the degree of occupancy by E12 and E47 in the <italic>Ig&#x003ba;</italic> and <italic>Ig&#x003bb;</italic> enhancers might be caused by interactions with other regulators. IRF-4 is an attractive candidate because it has been shown to bind cooperatively with the E proteins to sites present in the <italic>Ig&#x003ba;</italic> enhancers (<xref ref-type="bibr" rid="bib22">Johnson et al., 2008</xref>). Thus, initially, E47 levels might be limiting and act in concert with IRF-4 to drive <italic>Ig&#x003ba;</italic> VJ gene rearrangement but not to promote <italic>Ig&#x003bb;</italic> accessibility and DNA recombination. Later, during the pre&#x02013;B to the immature B cell transition, the absence of an <italic>Ig&#x003ba;</italic> or <italic>Ig&#x003bb;</italic> chain or the expression of a self-reactive BCR would increase E12 and E47 abundance to levels that allow sufficient occupancy at sites present in the <italic>Ig&#x003bb;</italic> enhancers and, thus, drive <italic>Ig&#x003bb;</italic> VJ recombination. On the other hand, because high levels of E47 reduce cell size and ultimately promote cell death, we suggest that the increase in E2A levels restricts the time that is available for the B cells to generate a useful receptor (<xref ref-type="fig" rid="fig8">Fig. 8</xref>; <xref ref-type="bibr" rid="bib13">Engel et al., 2001</xref>; <xref ref-type="bibr" rid="bib11">Engel and Murre, 2004</xref>). If, however, an innocuous BCR is generated, E12 and E47 abundance declines, resulting in a decrease in <italic>Ig&#x003ba;</italic> and <italic>Ig&#x003bb;</italic> occupancy and the promotion of positive selection (<xref ref-type="bibr" rid="bib39">Quong et al., 2004</xref>).</p><p>An intriguing question is how the E2A proteins modulate the assembly of such a diverse set of antigen receptor loci, and the data described in this study may help to illuminate the mechanism by which the E2A proteins contribute to antigen receptor recombination. Recently, it was shown that RAG2 associates with H3K4me3, establishing a direct link between epigenetic marking and antigen receptor assembly (<xref ref-type="bibr" rid="bib31">Liu et al., 2007</xref>; <xref ref-type="bibr" rid="bib33">Matthews et al., 2007</xref>; <xref ref-type="bibr" rid="bib41">Ram&#x000f3;n-Maiques et al., 2007</xref>). In this study, we demonstrate that E12 elevates the abundance of H3K4me3 across the Ig&#x003bb; J regions in B cells poised to undergo <italic>Ig&#x003bb;</italic> VJ gene rearrangement. Clearly, E12 is not the sole factor responsible for H3K4me3 because residual H3K4me3 remains across the J&#x003bb; region in E12-deficient B cells, and consequently, other factors must contribute as well. There are several possible mechanisms of how E12 might modulate the degree of H3K4me3. First, it is possible that E12 contributes directly to the recruitment of methyltransferase activity acting on H3K4. Alternatively, E12 may function indirectly by activating <italic>Ig&#x003bb;</italic> germline transcription, enabling methyltransferases and acetylases to travel with the RNA pol II complex, which then may lead to the trimethylation of H3K4. Collectively, these data have implications for the role of the E proteins in modulating the assembly of the large majority of antigen receptor loci (<xref ref-type="bibr" rid="bib34">Murre, 2005</xref>). We suggest that the E proteins, directly or indirectly and in conjunction with other factors, act to promote epigenetic marking of antigen receptor loci across J regions to permit the recruitment of the RAG2 component of the recombinase.</p><p>In conclusion, this study demonstrates the multiple and unique functions displayed by the E2A isoforms E12 and E47. E47 is essential during B cell specification, commitment, and maintenance and it is necessary but not sufficient during the sequential rearrangement of the <italic>Ig&#x003ba;</italic> and <italic>Ig&#x003bb;</italic> loci. E12 and E47 are both required to promote <italic>Ig&#x003bb;</italic> VJ rearrangement by modulating, at least in part, the trimethylation of H3K4 across the J&#x003bb; region. Finally, we propose that in the pre&#x02013;B and immature B cell compartments, a gradient of E12 and E47 activity is established to mechanistically regulate the sequential rearrangement of the Ig light chains.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title/><sec><title>Generation of specific E12- and E47-deficient mice.</title><p>The linearized targeting vector, containing either the E12 or the E47 exon flanked by two loxP sites as well as a C-terminal tetracysteine tag (<xref ref-type="bibr" rid="bib32">Martin et al., 2005</xref>), was electroporated into 129Sv/Ev ES cells, and correctly targeted clones were identified by Southern blot analyses using the enzymes and outside probe depicted in the figures. After injection into blastocysts and generation of chimeric mice the correctly germline-targeted mouse was backcrossed to Ella-<italic>cre</italic> mice to generate E12- and E47-deficient mice (<xref ref-type="bibr" rid="bib26">Lakso et al., 1996</xref>). Mice were genotyped using primers in <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">Table S1</ext-link>. All experiments using mice were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of the University of California, San Diego (UCSD).</p></sec><sec><title>Flow cytometry and cell sorting.</title><p>FACS analyses were performed with 8&#x02013;12-wk-old mice. Single cells were stained with various fluorochrome-conjugated antibodies purchased from eBioscience or BD. Data were collected with a flow cytometer (LSRII; BD) and were analyzed with FlowJo software (Tree Star, Inc.). Specific cell populations were either sorted on a FACSAria (BD) or isolated by magnetic cell sorting with anti-B220 or anti-biotin microbeads (Miltenyi Biotec) according to the manufacturer&#x02019;s protocol. The following antibodies were used for flow cytometry: anti-B220 (RA3-6B2); CD19 (1D3); CD43 (R2/60); BP-1 (6C3); CD24/HSA (M1/69); CD117/c-kit (2B8); CD25 (PC61); IgM (II/41); IgD (11-26); CD21 (8D9); CD23 (B3B4); Ig&#x003ba; light chain (187.1); Ig&#x003bb;1, &#x003bb;2, and &#x003bb;3 light chain (R26-46); Flt3 (AF10.1); CD127/IL-7R&#x003b1; (A7R34); Sca1 (D7); Ter119 (TER-119); Gr1 (RB6-8C5); CD11b/Mac1 (M1/70); and CD3&#x003b5; (145-2C11) and CD11c (N418). For CLP/LMPP sorting, the lineage cocktail contained antibodies against B220, Ter119, Gr1, CD11b/Mac1, CD3&#x003b5;, and CD11c. Unspecific antibody binding was prevented by preincubation with CD16/CD32 Fc blocking solution (eBioscience).</p></sec><sec><title>Quantitative RT-PCR.</title><p>Total RNA was isolated using the DNeasy kit (QIAGEN), and cDNA was prepared with oligo-dT primers using SuperScriptIII reverse transcription (Invitrogen). Quantitative PCR was performed using Brilliant SYBR Green Master Mix (Agilent Technologies) on the Mx3500P cycler (Agilent Technologies) using the gene-specific primers listed in <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">Table S2</ext-link> and a 60&#x000b0;C annealing temperature.</p></sec><sec><title>Bone marrow chimeras.</title><p>Recipients were either &#x003ba;-macroself transgenic mice or littermate controls that carried the CD45.1 allele and have been previously described (<xref ref-type="bibr" rid="bib2">Ait-Azzouzene et al., 2005</xref>). Recipients received 1,000 rads of &#x003b3; irradiation from a Cs source the day before transfer. Bone marrow donors were all of the CD45.2 allotype. Bone marrow cell suspensions were depleted of T cells by treatment with biotinylated anti-Thy1.2 antibodies and anti-biotin microbeads (Miltenyi Biotec). 10 million cells were transferred i.v. per recipient. After 6 wk, recipients were killed and their lymphoid tissues were analyzed by flow cytometry. Only chimeras in which &#x02265;98% of cells in the spleen were donor derived were included in the analysis.</p></sec><sec><title>PCR assays for Ig gene recombinations.</title><p>PCR reactions were performed in a final volume of 25 &#x000b5;l containing 4, 1, and 0.25 ng of genomic DNA using the primers listed in <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">Table S3</ext-link>. Specific probes were also generated by PCR using the primers listed in <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">Table S4</ext-link>, gel purified using the QIAquick Gel Extraction Kit (QIAGEN), and radioactively labeled using the Prime-It Kit (Agilent Technologies). Samples were amplified for 25 cycles of 94&#x000b0;C for 1 min, 60&#x000b0;C for 30 s, and 72&#x000b0;C for 1.5 min. PCR products were electrophoresed on 1.5% (0.8% for <italic>Ig&#x003ba;</italic> V-J) agarose gels, blotted on nylon membranes (Schleicher &#x00026; Schuell), and hybridized with radioactive probes. Signals were detected with a Phosphorimager (GE Healthcare) and analyzed using ImageJ software (available at <ext-link ext-link-type="uri" xlink:href="http://rsbweb.nih.gov/ij/">http://rsbweb.nih.gov/ij/</ext-link>).</p></sec><sec><title>ChIPs.</title><p>ChIP assays were performed as previously described (<xref ref-type="bibr" rid="bib1">Agata et al., 2007</xref>). In brief, B cells were fixed with 1% formaldehyde for 10 min at room temperature, lysed, and sonicated. Samples were precleared for 1 h with protein G beads, and ChIP was performed overnight using anti-E2A (anti-E12 V18; Santa Cruz Biotechnology, Inc.), anti-H3K4me3 (Millipore), anti&#x02013;acetyl H3K9/14 (Millipore), or control normal rabbit IgG (Santa Cruz Biotechnology, Inc.). After washing and elution of the beads, cross-linking was reversed and protein was digested by proteinase K treatment. ChIP DNA was isolated using QIAquick PCR Purification Kit (QIAGEN) and analyzed by quantitative PCR using Brilliant SYBR Green Master Mix on an Mx3500P and the gene-specific primers listed in <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">Table S5</ext-link>.</p></sec><sec><title>In vitro HEL-Tg B cell cultures.</title><p>HEL-Tg mice, which bear rearranged IgH and Ig&#x003ba; light chain genes that encode an HEL-specific BCR, were obtained from the Jackson Laboratory. Whole bone marrow was isolated from 4&#x02013;6-wk-old HEL-Tg mice, and red blood cells were lysed and cultured in RPMI 1640 medium with 10% (vol/vol) FCS, 100 U/ml penicillin-streptomycin, 2 mM <sc>l</sc>-glutamine, and 50 &#x000b5;M 2-mercaptoethanol in the presence of 1% conditioned supernatant of rIL-7&#x02013;producing J558L cells for 4 d at 37&#x000b0;C in 5% CO<sub>2</sub>. Remaining myeloid cells as well as surface IgD<sup>+</sup> B cells were depleted using magnetic cell sorting (Miltenyi Biotec), and purified B cells were cultured in the absence of IL-7. Cells were harvested at the time points indicated in the figures and used for quantitative PCR.</p></sec><sec><title>In vitro B cell cultures.</title><p>Total B cells from bone marrow were isolated using B220-coupled magnetic beads (Miltenyi Biotec) and cultured in OptiMEM medium with 10% (vol/vol) FCS, 100 U/ml penicillin-streptomycin, 2 mM <sc>l</sc>-glutamine, and 50 &#x000b5;M 2-mercaptoethanol in the presence of IL-7 and stem cell factor for 8 d at 37&#x000b0;C in 5% CO<sub>2</sub>. The remaining nonpro&#x02013;B cells were depleted using magnetic cell sorting (Miltenyi Biotec), and purified B cells were cultured in the absence of IL-7 for 18 h before they were used for ChIP.</p></sec><sec><title>Statistical analysis.</title><p>Statistical significance was calculated using the two-tailed Student&#x02019;s <italic>t</italic> test. P &#x0003c; 0.05 was considered significant.</p></sec><sec><title>Online supplemental material.</title><p>Fig. S1 shows c-kit staining in the bone marrow of E12- and E47-deficient mice. Fig. S2 shows <italic>E12</italic> and <italic>E47</italic> expression levels in LMPP and CLP cells. Fig. S3 is the analysis of bone marrow chimeras generated by transplanting wild-type and E12-deficient bone marrow cells into &#x003ba;-macroself transgenic mice. Fig. S4 shows <italic>IgH</italic> and <italic>Igk</italic> gene rearrangement. Fig. S5 shows <italic>RAG1</italic> and <italic>RAG2</italic> expression levels in pre&#x02013;B cells. Tables S1&#x02013;S5 list primer sequences used for PCR. Online supplemental material is available at <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20090756/DC1">http://www.jem.org/cgi/content/full/jem.20090756/DC1</ext-link>.</p></sec></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="PMC_1" content-type="local-data"><caption><title>[Supplemental Material]</title></caption><media mimetype="text" mime-subtype="html" xlink:href="jem.20090756_index.html"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="jem.20090756_1.pdf"/></supplementary-material></sec></body><back><ack><p>We thank Dr. S. Andre and E. Mercer for careful reading and editing of the manuscript, and members of the Murre laboratory for stimulating discussions; Dr. Y. Lin for technical advice with the ChIP experiments; E. Welinder and Dr. R. M&#x000e5;nsson for assistance with the CLP and LMPP sorting; B. Duong for assistance with the receptor editing experiment; K. Ong for assistance with FACS sorting; and the UCSD Transgenic and Gene Targeting Core for producing E12- and E47-deficient mice.</p><p>This study was supported by the National Institutes of Health (C. Murre and D. Nemazee).</p><p>The authors have no conflicting financial interests.</p></ack><ref-list><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agata</surname><given-names>Y.</given-names></name><name><surname>Tamaki</surname><given-names>N.</given-names></name><name><surname>Sakamoto</surname><given-names>S.</given-names></name><name><surname>Ikawa</surname><given-names>T.</given-names></name><name><surname>Masuda</surname><given-names>K.</given-names></name><name><surname>Kawamoto</surname><given-names>H.</given-names></name><name><surname>Murre</surname><given-names>C.</given-names></name></person-group><year>2007</year><article-title>Regulation of T cell receptor beta gene rearrangements and allelic exclusion by the helix-loop-helix protein, E47</article-title>.<source>Immunity.</source><volume>27</volume>:<fpage>871</fpage>&#x02013;<lpage>884</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.immuni.2007.11.015">10.1016/j.immuni.2007.11.015</ext-link></comment><pub-id pub-id-type="pmid">18093539</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ait-Azzouzene</surname><given-names>D.</given-names></name><name><surname>Verkoczy</surname><given-names>L.</given-names></name><name><surname>Peters</surname><given-names>J.</given-names></name><name><surname>Gavin</surname><given-names>A.</given-names></name><name><surname>Skog</surname><given-names>P.</given-names></name><name><surname>Vela</surname><given-names>J.L.</given-names></name><name><surname>Nemazee</surname><given-names>D.</given-names></name></person-group><year>2005</year><article-title>An immunoglobulin C&#x003ba;-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system</article-title>.<source>J. Exp. Med.</source><volume>201</volume>:<fpage>817</fpage>&#x02013;<lpage>828</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1084/jem.20041854">10.1084/jem.20041854</ext-link></comment><pub-id pub-id-type="pmid">15738053</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alt</surname><given-names>F.W.</given-names></name><name><surname>Yancopoulos</surname><given-names>G.D.</given-names></name><name><surname>Blackwell</surname><given-names>T.K.</given-names></name><name><surname>Wood</surname><given-names>C.</given-names></name><name><surname>Thomas</surname><given-names>E.</given-names></name><name><surname>Boss</surname><given-names>M.</given-names></name><name><surname>Coffman</surname><given-names>R.</given-names></name><name><surname>Rosenberg</surname><given-names>N.</given-names></name><name><surname>Tonegawa</surname><given-names>S.</given-names></name><name><surname>Baltimore</surname><given-names>D.</given-names></name></person-group><year>1984</year><article-title>Ordered rearrangement of immunoglobulin heavy chain variable region segments</article-title>.<source>EMBO J.</source><volume>3</volume>:<fpage>1209</fpage>&#x02013;<lpage>1219</lpage><pub-id pub-id-type="pmid">6086308</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bain</surname><given-names>G.</given-names></name><name><surname>Maandag</surname><given-names>E.C.</given-names></name><name><surname>Izon</surname><given-names>D.J.</given-names></name><name><surname>Amsen</surname><given-names>D.</given-names></name><name><surname>Kruisbeek</surname><given-names>A.M.</given-names></name><name><surname>Weintraub</surname><given-names>B.C.</given-names></name><name><surname>Krop</surname><given-names>I.</given-names></name><name><surname>Schlissel</surname><given-names>M.S.</given-names></name><name><surname>Feeney</surname><given-names>A.J.</given-names></name><name><surname>van Roon</surname><given-names>M.</given-names></name><etal/></person-group><year>1994</year><article-title>E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements</article-title>.<source>Cell.</source><volume>79</volume>:<fpage>885</fpage>&#x02013;<lpage>892</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/0092-8674(94)90077-9">10.1016/0092-8674(94)90077-9</ext-link></comment><pub-id pub-id-type="pmid">8001125</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bain</surname><given-names>G.</given-names></name><name><surname>Robanus Maandag</surname><given-names>E.C.</given-names></name><name><surname>te Riele</surname><given-names>H.P.</given-names></name><name><surname>Feeney</surname><given-names>A.J.</given-names></name><name><surname>Sheehy</surname><given-names>A.</given-names></name><name><surname>Schlissel</surname><given-names>M.</given-names></name><name><surname>Shinton</surname><given-names>S.A.</given-names></name><name><surname>Hardy</surname><given-names>R.R.</given-names></name><name><surname>Murre</surname><given-names>C.</given-names></name></person-group><year>1997</year><article-title>Both E12 and E47 allow commitment to the B cell lineage</article-title>.<source>Immunity.</source><volume>6</volume>:<fpage>145</fpage>&#x02013;<lpage>154</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/S1074-7613(00)80421-5">10.1016/S1074-7613(00)80421-5</ext-link></comment><pub-id pub-id-type="pmid">9047236</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benezra</surname><given-names>R.</given-names></name><name><surname>Davis</surname><given-names>R.L.</given-names></name><name><surname>Lassar</surname><given-names>A.</given-names></name><name><surname>Tapscott</surname><given-names>S.</given-names></name><name><surname>Thayer</surname><given-names>M.</given-names></name><name><surname>Lockshon</surname><given-names>D.</given-names></name><name><surname>Weintraub</surname><given-names>H.</given-names></name></person-group><year>1990</year><article-title>Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation</article-title>.<source>Ann. NY Acad. Sci.</source><volume>599</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1111/j.1749-6632.1990.tb42359.x">10.1111/j.1749-6632.1990.tb42359.x</ext-link></comment><pub-id pub-id-type="pmid">2171390</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borghesi</surname><given-names>L.</given-names></name><name><surname>Aites</surname><given-names>J.</given-names></name><name><surname>Nelson</surname><given-names>S.</given-names></name><name><surname>Lefterov</surname><given-names>P.</given-names></name><name><surname>James</surname><given-names>P.</given-names></name><name><surname>Gerstein</surname><given-names>R.</given-names></name></person-group><year>2005</year><article-title>E47 is required for V(D)J recombinase activity in common lymphoid progenitors</article-title>.<source>J. Exp. Med.</source><volume>202</volume>:<fpage>1669</fpage>&#x02013;<lpage>1677</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1084/jem.20051190">10.1084/jem.20051190</ext-link></comment><pub-id pub-id-type="pmid">16365147</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cedar</surname><given-names>H.</given-names></name><name><surname>Bergman</surname><given-names>Y.</given-names></name></person-group><year>1999</year><article-title>Developmental regulation of immune system gene rearrangement</article-title>.<source>Curr. Opin. Immunol.</source><volume>11</volume>:<fpage>64</fpage>&#x02013;<lpage>69</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/S0952-7915(99)80012-0">10.1016/S0952-7915(99)80012-0</ext-link></comment><pub-id pub-id-type="pmid">10047543</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corneliussen</surname><given-names>B.</given-names></name><name><surname>Thornell</surname><given-names>A.</given-names></name><name><surname>Hallberg</surname><given-names>B.</given-names></name><name><surname>Grundstr&#x000f6;m</surname><given-names>T.</given-names></name></person-group><year>1991</year><article-title>Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers</article-title>.<source>J. Virol.</source><volume>65</volume>:<fpage>6084</fpage>&#x02013;<lpage>6093</lpage><pub-id pub-id-type="pmid">1681116</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>S.</given-names></name><name><surname>M&#x000e5;nsson</surname><given-names>R.</given-names></name><name><surname>Gurbuxani</surname><given-names>S.</given-names></name><name><surname>Sigvardsson</surname><given-names>M.</given-names></name><name><surname>Kee</surname><given-names>B.L.</given-names></name></person-group><year>2008</year><article-title>E2A proteins promote development of lymphoid-primed multipotent progenitors</article-title>.<source>Immunity.</source><volume>29</volume>:<fpage>217</fpage>&#x02013;<lpage>227</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.immuni.2008.05.015">10.1016/j.immuni.2008.05.015</ext-link></comment><pub-id pub-id-type="pmid">18674933</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>I.</given-names></name><name><surname>Murre</surname><given-names>C.</given-names></name></person-group><year>2004</year><article-title>E2A proteins enforce a proliferation checkpoint in developing thymocytes</article-title>.<source>EMBO J.</source><volume>23</volume>:<fpage>202</fpage>&#x02013;<lpage>211</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1038/sj.emboj.7600017">10.1038/sj.emboj.7600017</ext-link></comment><pub-id pub-id-type="pmid">14685278</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>H.</given-names></name><name><surname>Rolink</surname><given-names>A.</given-names></name><name><surname>Weiss</surname><given-names>S.</given-names></name></person-group><year>1999</year><article-title>B cells are programmed to activate kappa and lambda for rearrangement at consecutive developmental stages</article-title>.<source>Eur. J. Immunol.</source><volume>29</volume>:<fpage>2167</fpage>&#x02013;<lpage>2176</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1002/(SICI)1521-4141(199907)29:07&#x0003c;2167::AID-IMMU2167&#x0003e;3.0.CO;2-H">10.1002/(SICI)1521-4141(199907)29:07&#x0003c;2167::AID-IMMU2167&#x0003e;3.0.CO;2-H</ext-link></comment><pub-id pub-id-type="pmid">10427979</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>I.</given-names></name><name><surname>Johns</surname><given-names>C.</given-names></name><name><surname>Bain</surname><given-names>G.</given-names></name><name><surname>Rivera</surname><given-names>R.R.</given-names></name><name><surname>Murre</surname><given-names>C.</given-names></name></person-group><year>2001</year><article-title>Early thymocyte development is regulated by modulation of E2A protein activity</article-title>.<source>J. Exp. Med.</source><volume>194</volume>:<fpage>733</fpage>&#x02013;<lpage>745</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1084/jem.194.6.733">10.1084/jem.194.6.733</ext-link></comment><pub-id pub-id-type="pmid">11560990</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gellert</surname><given-names>M.</given-names></name></person-group><year>2002</year><article-title>V(D)J recombination: RAG proteins, repair factors, and regulation</article-title>.<source>Annu. Rev. Biochem.</source><volume>71</volume>:<fpage>101</fpage>&#x02013;<lpage>132</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1146/annurev.biochem.71.090501.150203">10.1146/annurev.biochem.71.090501.150203</ext-link></comment><pub-id pub-id-type="pmid">12045092</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goebel</surname><given-names>P.</given-names></name><name><surname>Janney</surname><given-names>N.</given-names></name><name><surname>Valenzuela</surname><given-names>J.R.</given-names></name><name><surname>Romanow</surname><given-names>W.J.</given-names></name><name><surname>Murre</surname><given-names>C.</given-names></name><name><surname>Feeney</surname><given-names>A.J.</given-names></name></person-group><year>2001</year><article-title>Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells</article-title>.<source>J. Exp. Med.</source><volume>194</volume>:<fpage>645</fpage>&#x02013;<lpage>656</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1084/jem.194.5.645">10.1084/jem.194.5.645</ext-link></comment><pub-id pub-id-type="pmid">11535632</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenbaum</surname><given-names>S.</given-names></name><name><surname>Zhuang</surname><given-names>Y.</given-names></name></person-group><year>2002a</year><article-title>Identification of E2A target genes in B lymphocyte development by using a gene tagging-based chromatin immunoprecipitation system</article-title>.<source>Proc. Natl. Acad. Sci. USA.</source><volume>99</volume>:<fpage>15030</fpage>&#x02013;<lpage>15035</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1073/pnas.232299999">10.1073/pnas.232299999</ext-link></comment><pub-id pub-id-type="pmid">12415115</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenbaum</surname><given-names>S.</given-names></name><name><surname>Zhuang</surname><given-names>Y.</given-names></name></person-group><year>2002b</year><article-title>Regulation of early lymphocyte development by E2A family proteins</article-title>.<source>Semin. Immunol.</source><volume>14</volume>:<fpage>405</fpage>&#x02013;<lpage>414</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/S1044532302000751">10.1016/S1044532302000751</ext-link></comment><pub-id pub-id-type="pmid">12457613</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>R.R.</given-names></name><name><surname>Hayakawa</surname><given-names>K.</given-names></name></person-group><year>2001</year><article-title>B cell development pathways</article-title>.<source>Annu. Rev. Immunol.</source><volume>19</volume>:<fpage>595</fpage>&#x02013;<lpage>621</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1146/annurev.immunol.19.1.595">10.1146/annurev.immunol.19.1.595</ext-link></comment><pub-id pub-id-type="pmid">11244048</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>R.R.</given-names></name><name><surname>Kincade</surname><given-names>P.W.</given-names></name><name><surname>Dorshkind</surname><given-names>K.</given-names></name></person-group><year>2007</year><article-title>The protean nature of cells in the B lymphocyte lineage</article-title>.<source>Immunity.</source><volume>26</volume>:<fpage>703</fpage>&#x02013;<lpage>714</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.immuni.2007.05.013">10.1016/j.immuni.2007.05.013</ext-link></comment><pub-id pub-id-type="pmid">17582343</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikawa</surname><given-names>T.</given-names></name><name><surname>Kawamoto</surname><given-names>H.</given-names></name><name><surname>Wright</surname><given-names>L.Y.</given-names></name><name><surname>Murre</surname><given-names>C.</given-names></name></person-group><year>2004</year><article-title>Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent</article-title>.<source>Immunity.</source><volume>20</volume>:<fpage>349</fpage>&#x02013;<lpage>360</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/S1074-7613(04)00049-4">10.1016/S1074-7613(04)00049-4</ext-link></comment><pub-id pub-id-type="pmid">15030778</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inlay</surname><given-names>M.A.</given-names></name><name><surname>Tian</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name></person-group><year>2004</year><article-title>Important roles for E protein binding sites within the immunoglobulin &#x003ba; chain intronic enhancer in activating V&#x003ba; J&#x003ba; rearrangement</article-title>.<source>J. Exp. Med.</source><volume>200</volume>:<fpage>1205</fpage>&#x02013;<lpage>1211</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1084/jem.20041135">10.1084/jem.20041135</ext-link></comment><pub-id pub-id-type="pmid">15504821</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>K.</given-names></name><name><surname>Hashimshony</surname><given-names>T.</given-names></name><name><surname>Sawai</surname><given-names>C.M.</given-names></name><name><surname>Pongubala</surname><given-names>J.M.</given-names></name><name><surname>Skok</surname><given-names>J.A.</given-names></name><name><surname>Aifantis</surname><given-names>I.</given-names></name><name><surname>Singh</surname><given-names>H.</given-names></name></person-group><year>2008</year><article-title>Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling</article-title>.<source>Immunity.</source><volume>28</volume>:<fpage>335</fpage>&#x02013;<lpage>345</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.immuni.2007.12.019">10.1016/j.immuni.2007.12.019</ext-link></comment><pub-id pub-id-type="pmid">18280186</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kee</surname><given-names>B.L.</given-names></name><name><surname>Paige</surname><given-names>C.J.</given-names></name></person-group><year>1995</year><article-title>Murine B cell development: commitment and progression from multipotential progenitors to mature B lymphocytes</article-title>.<source>Int. Rev. Cytol.</source><volume>157</volume>:<fpage>129</fpage>&#x02013;<lpage>179</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/S0074-7696(08)62158-0">10.1016/S0074-7696(08)62158-0</ext-link></comment><pub-id pub-id-type="pmid">7706019</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kee</surname><given-names>B.L.</given-names></name><name><surname>Bain</surname><given-names>G.</given-names></name><name><surname>Murre</surname><given-names>C.</given-names></name></person-group><year>2002</year><article-title>IL-7Ralpha and E47: independent pathways required for development of multipotent lymphoid progenitors</article-title>.<source>EMBO J.</source><volume>21</volume>:<fpage>103</fpage>&#x02013;<lpage>113</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1093/emboj/21.1.103">10.1093/emboj/21.1.103</ext-link></comment><pub-id pub-id-type="pmid">11782430</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>K.</given-names></name><name><surname>Hutter</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name><name><surname>Bilic</surname><given-names>I.</given-names></name><name><surname>Cobaleda</surname><given-names>C.</given-names></name><name><surname>Malin</surname><given-names>S.</given-names></name><name><surname>Busslinger</surname><given-names>M.</given-names></name></person-group><year>2008</year><article-title>Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development</article-title>.<source>Immunity.</source><volume>28</volume>:<fpage>751</fpage>&#x02013;<lpage>762</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.immuni.2008.04.014">10.1016/j.immuni.2008.04.014</ext-link></comment><pub-id pub-id-type="pmid">18538592</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakso</surname><given-names>M.</given-names></name><name><surname>Pichel</surname><given-names>J.G.</given-names></name><name><surname>Gorman</surname><given-names>J.R.</given-names></name><name><surname>Sauer</surname><given-names>B.</given-names></name><name><surname>Okamoto</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>E.</given-names></name><name><surname>Alt</surname><given-names>F.W.</given-names></name><name><surname>Westphal</surname><given-names>H.</given-names></name></person-group><year>1996</year><article-title>Efficient in vivo manipulation of mouse genomic sequences at the zygote stage</article-title>.<source>Proc. Natl. Acad. Sci. USA.</source><volume>93</volume>:<fpage>5860</fpage>&#x02013;<lpage>5865</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1073/pnas.93.12.5860">10.1073/pnas.93.12.5860</ext-link></comment><pub-id pub-id-type="pmid">8650183</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazorchak</surname><given-names>A.</given-names></name><name><surname>Jones</surname><given-names>M.E.</given-names></name><name><surname>Zhuang</surname><given-names>Y.</given-names></name></person-group><year>2005</year><article-title>New insights into E-protein function in lymphocyte development</article-title>.<source>Trends Immunol.</source><volume>26</volume>:<fpage>334</fpage>&#x02013;<lpage>338</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.it.2005.03.011">10.1016/j.it.2005.03.011</ext-link></comment><pub-id pub-id-type="pmid">15922950</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazorchak</surname><given-names>A.S.</given-names></name><name><surname>Schlissel</surname><given-names>M.S.</given-names></name><name><surname>Zhuang</surname><given-names>Y.</given-names></name></person-group><year>2006a</year><article-title>E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells</article-title>.<source>Mol. Cell. Biol.</source><volume>26</volume>:<fpage>810</fpage>&#x02013;<lpage>821</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1128/MCB.26.3.810-821.2006">10.1128/MCB.26.3.810-821.2006</ext-link></comment><pub-id pub-id-type="pmid">16428437</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazorchak</surname><given-names>A.S.</given-names></name><name><surname>Wojciechowski</surname><given-names>J.</given-names></name><name><surname>Dai</surname><given-names>M.</given-names></name><name><surname>Zhuang</surname><given-names>Y.</given-names></name></person-group><year>2006b</year><article-title>E2A promotes the survival of precursor and mature B lymphocytes</article-title>.<source>J. Immunol.</source><volume>177</volume>:<fpage>2495</fpage>&#x02013;<lpage>2504</lpage><pub-id pub-id-type="pmid">16888011</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Grosschedl</surname><given-names>R.</given-names></name></person-group><year>1995</year><article-title>Failure of B-cell differentiation in mice lacking the transcription factor EBF</article-title>.<source>Nature.</source><volume>376</volume>:<fpage>263</fpage>&#x02013;<lpage>267</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1038/376263a0">10.1038/376263a0</ext-link></comment><pub-id pub-id-type="pmid">7542362</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Subrahmanyam</surname><given-names>R.</given-names></name><name><surname>Chakraborty</surname><given-names>T.</given-names></name><name><surname>Sen</surname><given-names>R.</given-names></name><name><surname>Desiderio</surname><given-names>S.</given-names></name></person-group><year>2007</year><article-title>A plant homeodomain in RAG-2 that binds hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement</article-title>.<source>Immunity.</source><volume>27</volume>:<fpage>561</fpage>&#x02013;<lpage>571</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.immuni.2007.09.005">10.1016/j.immuni.2007.09.005</ext-link></comment><pub-id pub-id-type="pmid">17936034</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>B.R.</given-names></name><name><surname>Giepmans</surname><given-names>B.N.</given-names></name><name><surname>Adams</surname><given-names>S.R.</given-names></name><name><surname>Tsien</surname><given-names>R.Y.</given-names></name></person-group><year>2005</year><article-title>Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity</article-title>.<source>Nat. Biotechnol.</source><volume>23</volume>:<fpage>1308</fpage>&#x02013;<lpage>1314</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1038/nbt1136">10.1038/nbt1136</ext-link></comment><pub-id pub-id-type="pmid">16155565</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>A.G.</given-names></name><name><surname>Kuo</surname><given-names>A.J.</given-names></name><name><surname>Ram&#x000f3;n-Maiques</surname><given-names>S.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Champagne</surname><given-names>K.S.</given-names></name><name><surname>Ivanov</surname><given-names>D.</given-names></name><name><surname>Gallardo</surname><given-names>M.</given-names></name><name><surname>Carney</surname><given-names>D.</given-names></name><name><surname>Cheung</surname><given-names>P.</given-names></name><name><surname>Ciccone</surname><given-names>D.N.</given-names></name><etal/></person-group><year>2007</year><article-title>RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination</article-title>.<source>Nature.</source><volume>450</volume>:<fpage>1106</fpage>&#x02013;<lpage>1110</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1038/nature06431">10.1038/nature06431</ext-link></comment><pub-id pub-id-type="pmid">18033247</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murre</surname><given-names>C.</given-names></name></person-group><year>2005</year><article-title>Helix-loop-helix proteins and lymphocyte development</article-title>.<source>Nat. Immunol.</source><volume>6</volume>:<fpage>1079</fpage>&#x02013;<lpage>1086</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1038/ni1260">10.1038/ni1260</ext-link></comment><pub-id pub-id-type="pmid">16239924</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murre</surname><given-names>C.</given-names></name><name><surname>McCaw</surname><given-names>P.S.</given-names></name><name><surname>Baltimore</surname><given-names>D.</given-names></name></person-group><year>1989</year><article-title>A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins</article-title>.<source>Cell.</source><volume>56</volume>:<fpage>777</fpage>&#x02013;<lpage>783</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/0092-8674(89)90682-X">10.1016/0092-8674(89)90682-X</ext-link></comment><pub-id pub-id-type="pmid">2493990</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadel</surname><given-names>B.</given-names></name><name><surname>Cazenave</surname><given-names>P.A.</given-names></name><name><surname>Sanchez</surname><given-names>P.</given-names></name></person-group><year>1990</year><article-title>Murine lambda gene rearrangements: the stochastic model prevails over the ordered model</article-title>.<source>EMBO J.</source><volume>9</volume>:<fpage>435</fpage>&#x02013;<lpage>440</lpage><pub-id pub-id-type="pmid">2105884</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemazee</surname><given-names>D.</given-names></name></person-group><year>2006</year><article-title>Receptor editing in lymphocyte development and central tolerance</article-title>.<source>Nat. Rev. Immunol.</source><volume>6</volume>:<fpage>728</fpage>&#x02013;<lpage>740</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1038/nri1939">10.1038/nri1939</ext-link></comment><pub-id pub-id-type="pmid">16998507</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nutt</surname><given-names>S.L.</given-names></name><name><surname>Kee</surname><given-names>B.L.</given-names></name></person-group><year>2007</year><article-title>The transcriptional regulation of B cell lineage commitment</article-title>.<source>Immunity.</source><volume>26</volume>:<fpage>715</fpage>&#x02013;<lpage>725</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.immuni.2007.05.010">10.1016/j.immuni.2007.05.010</ext-link></comment><pub-id pub-id-type="pmid">17582344</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quong</surname><given-names>M.W.</given-names></name><name><surname>Martensson</surname><given-names>A.</given-names></name><name><surname>Langerak</surname><given-names>A.W.</given-names></name><name><surname>Rivera</surname><given-names>R.R.</given-names></name><name><surname>Nemazee</surname><given-names>D.</given-names></name><name><surname>Murre</surname><given-names>C.</given-names></name></person-group><year>2004</year><article-title>Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A</article-title>.<source>J. Exp. Med.</source><volume>199</volume>:<fpage>1101</fpage>&#x02013;<lpage>1112</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1084/jem.20031180">10.1084/jem.20031180</ext-link></comment><pub-id pub-id-type="pmid">15078898</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radic</surname><given-names>M.Z.</given-names></name><name><surname>Erikson</surname><given-names>J.</given-names></name><name><surname>Litwin</surname><given-names>S.</given-names></name><name><surname>Weigert</surname><given-names>M.</given-names></name></person-group><year>1993</year><article-title>B lymphocytes may escape tolerance by revising their antigen receptors</article-title>.<source>J. Exp. Med.</source><volume>177</volume>:<fpage>1165</fpage>&#x02013;<lpage>1173</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1084/jem.177.4.1165">10.1084/jem.177.4.1165</ext-link></comment><pub-id pub-id-type="pmid">8459210</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000f3;n-Maiques</surname><given-names>S.</given-names></name><name><surname>Kuo</surname><given-names>A.J.</given-names></name><name><surname>Carney</surname><given-names>D.</given-names></name><name><surname>Matthews</surname><given-names>A.G.</given-names></name><name><surname>Oettinger</surname><given-names>M.A.</given-names></name><name><surname>Gozani</surname><given-names>O.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name></person-group><year>2007</year><article-title>The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2</article-title>.<source>Proc. Natl. Acad. Sci. USA.</source><volume>104</volume>:<fpage>18993</fpage>&#x02013;<lpage>18998</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1073/pnas.0709170104">10.1073/pnas.0709170104</ext-link></comment><pub-id pub-id-type="pmid">18025461</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roessler</surname><given-names>S.</given-names></name><name><surname>Gy&#x000f6;ry</surname><given-names>I.</given-names></name><name><surname>Imhof</surname><given-names>S.</given-names></name><name><surname>Spivakov</surname><given-names>M.</given-names></name><name><surname>Williams</surname><given-names>R.R.</given-names></name><name><surname>Busslinger</surname><given-names>M.</given-names></name><name><surname>Fisher</surname><given-names>A.G.</given-names></name><name><surname>Grosschedl</surname><given-names>R.</given-names></name></person-group><year>2007</year><article-title>Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5</article-title>.<source>Mol. Cell. Biol.</source><volume>27</volume>:<fpage>579</fpage>&#x02013;<lpage>594</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1128/MCB.01192-06">10.1128/MCB.01192-06</ext-link></comment><pub-id pub-id-type="pmid">17101802</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanow</surname><given-names>W.J.</given-names></name><name><surname>Langerak</surname><given-names>A.W.</given-names></name><name><surname>Goebel</surname><given-names>P.</given-names></name><name><surname>Wolvers-Tettero</surname><given-names>I.L.</given-names></name><name><surname>van Dongen</surname><given-names>J.J.</given-names></name><name><surname>Feeney</surname><given-names>A.J.</given-names></name><name><surname>Murre</surname><given-names>C.</given-names></name></person-group><year>2000</year><article-title>E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells</article-title>.<source>Mol. Cell.</source><volume>5</volume>:<fpage>343</fpage>&#x02013;<lpage>353</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/S1097-2765(00)80429-3">10.1016/S1097-2765(00)80429-3</ext-link></comment><pub-id pub-id-type="pmid">10882075</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudin</surname><given-names>C.M.</given-names></name><name><surname>Storb</surname><given-names>U.</given-names></name></person-group><year>1992</year><article-title>Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors</article-title>.<source>Mol. Cell. Biol.</source><volume>12</volume>:<fpage>309</fpage>&#x02013;<lpage>320</lpage><pub-id pub-id-type="pmid">1729607</pub-id></mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schebesta</surname><given-names>M.</given-names></name><name><surname>Pfeffer</surname><given-names>P.L.</given-names></name><name><surname>Busslinger</surname><given-names>M.</given-names></name></person-group><year>2002</year><article-title>Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene</article-title>.<source>Immunity.</source><volume>17</volume>:<fpage>473</fpage>&#x02013;<lpage>485</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/S1074-7613(02)00418-1">10.1016/S1074-7613(02)00418-1</ext-link></comment><pub-id pub-id-type="pmid">12387741</pub-id></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seet</surname><given-names>C.S.</given-names></name><name><surname>Brumbaugh</surname><given-names>R.L.</given-names></name><name><surname>Kee</surname><given-names>B.L.</given-names></name></person-group><year>2004</year><article-title>Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A</article-title>.<source>J. Exp. Med.</source><volume>199</volume>:<fpage>1689</fpage>&#x02013;<lpage>1700</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1084/jem.20032202">10.1084/jem.20032202</ext-link></comment><pub-id pub-id-type="pmid">15210745</pub-id></mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semerad</surname><given-names>C.L.</given-names></name><name><surname>Mercer</surname><given-names>E.M.</given-names></name><name><surname>Inlay</surname><given-names>M.A.</given-names></name><name><surname>Weissman</surname><given-names>I.L.</given-names></name><name><surname>Murre</surname><given-names>C.</given-names></name></person-group><year>2009</year><article-title>E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors</article-title>.<source>Proc. Natl. Acad. Sci. USA.</source><volume>106</volume>:<fpage>1930</fpage>&#x02013;<lpage>1935</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1073/pnas.0808866106">10.1073/pnas.0808866106</ext-link></comment><pub-id pub-id-type="pmid">19181846</pub-id></mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>H.</given-names></name><name><surname>Pongubala</surname><given-names>J.M.</given-names></name><name><surname>Medina</surname><given-names>K.L.</given-names></name></person-group><year>2007</year><article-title>Gene regulatory networks that orchestrate the development of B lymphocyte precursors</article-title>.<source>Adv. Exp. Med. Biol.</source><volume>596</volume>:<fpage>57</fpage>&#x02013;<lpage>62</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1007/0-387-46530-8_5">10.1007/0-387-46530-8_5</ext-link></comment><pub-id pub-id-type="pmid">17338175</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X.H.</given-names></name><name><surname>Baltimore</surname><given-names>D.</given-names></name></person-group><year>1991</year><article-title>An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers</article-title>.<source>Cell.</source><volume>64</volume>:<fpage>459</fpage>&#x02013;<lpage>470</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/0092-8674(91)90653-G">10.1016/0092-8674(91)90653-G</ext-link></comment><pub-id pub-id-type="pmid">1846322</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiegs</surname><given-names>S.L.</given-names></name><name><surname>Russell</surname><given-names>D.M.</given-names></name><name><surname>Nemazee</surname><given-names>D.</given-names></name></person-group><year>1993</year><article-title>Receptor editing in self-reactive bone marrow B cells</article-title>.<source>J. Exp. Med.</source><volume>177</volume>:<fpage>1009</fpage>&#x02013;<lpage>1020</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1084/jem.177.4.1009">10.1084/jem.177.4.1009</ext-link></comment><pub-id pub-id-type="pmid">8459201</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vela</surname><given-names>J.L.</given-names></name><name><surname>A&#x000ef;t-Azzouzene</surname><given-names>D.</given-names></name><name><surname>Duong</surname><given-names>B.H.</given-names></name><name><surname>Ota</surname><given-names>T.</given-names></name><name><surname>Nemazee</surname><given-names>D.</given-names></name></person-group><year>2008</year><article-title>Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production</article-title>.<source>Immunity.</source><volume>28</volume>:<fpage>161</fpage>&#x02013;<lpage>170</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.immuni.2007.12.011">10.1016/j.immuni.2007.12.011</ext-link></comment><pub-id pub-id-type="pmid">18261939</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Claus</surname><given-names>C.L.</given-names></name><name><surname>Vaccarelli</surname><given-names>G.</given-names></name><name><surname>Braunstein</surname><given-names>M.</given-names></name><name><surname>Schmitt</surname><given-names>T.M.</given-names></name><name><surname>Z&#x000fa;&#x000f1;iga-Pfl&#x000fc;cker</surname><given-names>J.C.</given-names></name><name><surname>Rothenberg</surname><given-names>E.V.</given-names></name><name><surname>Anderson</surname><given-names>M.K.</given-names></name></person-group><year>2006</year><article-title>The basic helix-loop-helix transcription factor HEBAlt is expressed in pro-T cells and enhances the generation of T cell precursors</article-title>.<source>J. Immunol.</source><volume>177</volume>:<fpage>109</fpage>&#x02013;<lpage>119</lpage><pub-id pub-id-type="pmid">16785505</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C.R.</given-names></name><name><surname>Feeney</surname><given-names>A.J.</given-names></name></person-group><year>2009</year><article-title>The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling</article-title>.<source>J. Immunol.</source><volume>182</volume>:<fpage>1362</fpage>&#x02013;<lpage>1369</lpage><pub-id pub-id-type="pmid">19155482</pub-id></mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Kardava</surname><given-names>L.</given-names></name><name><surname>St Leger</surname><given-names>A.</given-names></name><name><surname>Martincic</surname><given-names>K.</given-names></name><name><surname>Varnum-Finney</surname><given-names>B.</given-names></name><name><surname>Bernstein</surname><given-names>I.D.</given-names></name><name><surname>Milcarek</surname><given-names>C.</given-names></name><name><surname>Borghesi</surname><given-names>L.</given-names></name></person-group><year>2008</year><article-title>E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors</article-title>.<source>J. Immunol.</source><volume>181</volume>:<fpage>5885</fpage>&#x02013;<lpage>5894</lpage><pub-id pub-id-type="pmid">18941177</pub-id></mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>Y.</given-names></name><name><surname>Soriano</surname><given-names>P.</given-names></name><name><surname>Weintraub</surname><given-names>H.</given-names></name></person-group><year>1994</year><article-title>The helix-loop-helix gene E2A is required for B cell formation</article-title>.<source>Cell.</source><volume>79</volume>:<fpage>875</fpage>&#x02013;<lpage>884</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/0092-8674(94)90076-0">10.1016/0092-8674(94)90076-0</ext-link></comment><pub-id pub-id-type="pmid">8001124</pub-id></mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>Y.</given-names></name><name><surname>Jackson</surname><given-names>A.</given-names></name><name><surname>Pan</surname><given-names>L.</given-names></name><name><surname>Shen</surname><given-names>K.</given-names></name><name><surname>Dai</surname><given-names>M.</given-names></name></person-group><year>2004</year><article-title>Regulation of E2A gene expression in B-lymphocyte development</article-title>.<source>Mol. Immunol.</source><volume>40</volume>:<fpage>1165</fpage>&#x02013;<lpage>1177</lpage><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.molimm.2003.11.031">10.1016/j.molimm.2003.11.031</ext-link></comment><pub-id pub-id-type="pmid">15104122</pub-id></mixed-citation></ref></ref-list><fn-group><fn><p><def-list><title>Abbreviations used:</title><def-item><term>BCR</term><def><p>B cell receptor</p></def></def-item><def-item><term>ChIP</term><def><p>chromatin immunoprecipitation</p></def></def-item><def-item><term>CLP</term><def><p>common lymphoid progenitor</p></def></def-item><def-item><term>EBF</term><def><p>early B cell factor</p></def></def-item><def-item><term>ES</term><def><p>embryonic stem</p></def></def-item><def-item><term>H3</term><def><p>histone 3</p></def></def-item><def-item><term>H3ac</term><def><p>H3 acetylation</p></def></def-item><def-item><term>H3K4me3</term><def><p>trimethylated lysine 4 on H3</p></def></def-item><def-item><term>HEL-Tg</term><def><p>hen egg lysozyme transgene</p></def></def-item><def-item><term>HLH</term><def><p>helix-loop-helix</p></def></def-item><def-item><term><italic>Hprt1</italic></term><def><p>hypoxanthine guanine phosphoribosyl transferase 1</p></def></def-item><def-item><term>HSA</term><def><p>heat stable antigen</p></def></def-item><def-item><term>HSC</term><def><p>hematopoietic stem cell</p></def></def-item><def-item><term>iE&#x003ba;</term><def><p><italic>Ig&#x003ba;</italic> intronic enhancer</p></def></def-item><def-item><term><italic>IgH</italic></term><def><p>Ig heavy chain</p></def></def-item><def-item><term>LMPP</term><def><p>lymphoid-primed multipotent progenitor</p></def></def-item><def-item><term>RS</term><def><p>recombining sequence</p></def></def-item></def-list></p></fn></fn-group></back></article>